• Home
  • About
  • Browse
  • Help
  • Download

Plant Name: Dioscorea japonica




Collective Molecular Activities at 10μM Activity Cutoff

List of Human Proteins Collectively Targeted by the Plant

Target Activity Range: ≤ 10μM
Click Gene ID to Access Activity Profile of Individual Target
Target Class
Target Proteins
Small molecule receptor (family A GPCR)
GPR35; FFAR1; FFAR4; DRD4; ADRA2C; ADRA2A;
Peptide receptor (family A GPCR)
TSHR; NPSR1; CXCR1; NMUR2;
Enzyme_unclassified
AMY1A;AMY1B;AMY1C; RECQL; TDP1; PLA2G1B; BLM; APOBEC3G; FAAH; CTDSP1; TERT; PKM; PIK3CG; PIK3R1; GLO1; HPGD; PGD; MPO; HSD17B1; AKR1B1; HSD17B2; HSD17B10; ALOX15; ALDH1A1; ALOX12; NOX4; USP2; PYGL; APEX1; POLB;
Hydrolase
ACHE; GAA;
Protein Phosphatase
DUSP3;
Miscellaneous ion channel
BCL2;
Isomerase
TOP2A;
Protein Kinase
NEK6; AKT1; MET; CAMK2B; GSK3B; CSNK2A1; DAPK1; SYK; AXL; FLT3; SRC; IGF1R; PTK2; BRAF; AURKB; AURKA; DYRK1A; FLT4; EPHB4; MAP3K8; TEK; PDGFRB; INSR; PLK4; CDK1; MAPK1; MAPK14; ERBB2; EGFR; PIM1; NUAK1; ALK; MYLK; NEK2; KDR; PLK1; PKN1;
Lyase
CA14; CA7; CA3; CA5B; CA5A; CA1; CA9; CA13; CA4; CA6; CA2; CA12;
Nuclear hormone receptor subfamily 3 group C
AR;
Nuclear hormone receptor subfamily 1 group I
NR1I2;
Nuclear hormone receptor subfamily 3 group B
ESRRA;
Nuclear hormone receptor subfamily 1 group C
PPARA; PPARG; PPARD;
Nuclear hormone receptor subfamily 1 group H
NR1H3;
Lysine demethylase
KDM4E;
Oxidoreductase
MAOA; PTGS1; ALOX5; TYR; XDH;
Serine protease
F10; F2;
Metallo protease
MMP13; MMP2; MMP3; MMP14; MMP9;
Aspartic protease
BACE1;
Toll-like and Il-1 receptors
TLR2;
Transcription Factor
AHR; STAT6; HIF1A; NFKB1; TP53;
DNA methyltransferase
DNMT1;
Transferase
FUT7;
ATP-binding cassette
ABCC1; ABCB1; ABCG2;
SLC superfamily of solute carriers
SLC22A6; SLCO1B1; SLCO1B3;
Unclassified
SMAD3; LMNA; FABP4; MAPT; FABP3; FABP5; HBB; THPO; HTT; FABP2; APP; HSPA1A;
Methyl-lysine/arginine binding protein
L3MBTL1;


List of Human Cytochrome P450 Enzymes Affected by the Plant

Activity Range: ≤ 10μM
Click Gene ID to Access Activity Profile of Individual Enzyme
Cytochrome P450 Enzymes: CYP19A1; CYP1A2; CYP2C19; CYP2C9; CYP2C8; CYP3A4; CYP1B1; CYP1A1;

Detailed Information of Human Protein Targets

Protein Class Gene ID Protein Name Uniprot ID Target ChEMBL ID
Aspartic protease BACE1 Beta-secretase 1 P56817 CHEMBL4822
ATP-binding cassette ABCC1 Multidrug resistance-associated protein 1 P33527 CHEMBL3004
ATP-binding cassette ABCB1 P-glycoprotein 1 P08183 CHEMBL4302
ATP-binding cassette ABCG2 ATP-binding cassette sub-family G member 2 Q9UNQ0 CHEMBL5393
Cytochrome P450 family 1 CYP1A2 Cytochrome P450 1A2 P05177 CHEMBL3356
Cytochrome P450 family 1 CYP1B1 Cytochrome P450 1B1 Q16678 CHEMBL4878
Cytochrome P450 family 1 CYP1A1 Cytochrome P450 1A1 P04798 CHEMBL2231
Cytochrome P450 family 19 CYP19A1 Cytochrome P450 19A1 P11511 CHEMBL1978
Cytochrome P450 family 2 CYP2C19 Cytochrome P450 2C19 P33261 CHEMBL3622
Cytochrome P450 family 2 CYP2C9 Cytochrome P450 2C9 P11712 CHEMBL3397
Cytochrome P450 family 2 CYP2C8 Cytochrome P450 2C8 P10632 CHEMBL3721
Cytochrome P450 family 3 CYP3A4 Cytochrome P450 3A4 P08684 CHEMBL340
DNA methyltransferase DNMT1 DNA (cytosine-5)-methyltransferase 1 P26358 CHEMBL1993
Enzyme_unclassified PIK3R1 PI3-kinase p85-alpha subunit P27986 CHEMBL2506
Enzyme_unclassified GLO1 Glyoxalase I Q04760 CHEMBL2424
Enzyme_unclassified HPGD 15-hydroxyprostaglandin dehydrogenase [NAD+] P15428 CHEMBL1293255
Enzyme_unclassified PGD 6-phosphogluconate dehydrogenase P52209 CHEMBL3404
Enzyme_unclassified MPO Myeloperoxidase P05164 CHEMBL2439
Enzyme_unclassified HSD17B1 Estradiol 17-beta-dehydrogenase 1 P14061 CHEMBL3181
Enzyme_unclassified AKR1B1 Aldose reductase P15121 CHEMBL1900
Enzyme_unclassified HSD17B2 Estradiol 17-beta-dehydrogenase 2 P37059 CHEMBL2789
Enzyme_unclassified HSD17B10 Endoplasmic reticulum-associated amyloid beta-peptide-binding protein Q99714 CHEMBL4159
Enzyme_unclassified ALOX15 Arachidonate 15-lipoxygenase P16050 CHEMBL2903
Enzyme_unclassified ALDH1A1 Aldehyde dehydrogenase 1A1 P00352 CHEMBL3577
Enzyme_unclassified ALOX12 Arachidonate 12-lipoxygenase P18054 CHEMBL3687
Enzyme_unclassified NOX4 NADPH oxidase 4 Q9NPH5 CHEMBL1250375
Enzyme_unclassified USP2 Ubiquitin carboxyl-terminal hydrolase 2 O75604 CHEMBL1293227
Enzyme_unclassified PYGL Liver glycogen phosphorylase P06737 CHEMBL2568
Enzyme_unclassified APEX1 DNA-(apurinic or apyrimidinic site) lyase P27695 CHEMBL5619
Enzyme_unclassified POLB DNA polymerase beta P06746 CHEMBL2392
Enzyme_unclassified AMY1A;AMY1B;AMY1C Salivary alpha-amylase P04745 CHEMBL2478
Enzyme_unclassified RECQL ATP-dependent DNA helicase Q1 P46063 CHEMBL1293236
Enzyme_unclassified TDP1 Tyrosyl-DNA phosphodiesterase 1 Q9NUW8 CHEMBL1075138
Enzyme_unclassified PLA2G1B Phospholipase A2 group 1B P04054 CHEMBL4426
Enzyme_unclassified BLM Bloom syndrome protein P54132 CHEMBL1293237
Enzyme_unclassified APOBEC3G DNA dC->dU-editing enzyme APOBEC-3G Q9HC16 CHEMBL1741217
Enzyme_unclassified FAAH Anandamide amidohydrolase O00519 CHEMBL2243
Enzyme_unclassified CTDSP1 Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 Q9GZU7 CHEMBL1795098
Enzyme_unclassified TERT Telomerase reverse transcriptase O14746 CHEMBL2916
Enzyme_unclassified PKM Pyruvate kinase isozymes M1/M2 P14618 CHEMBL1075189
Enzyme_unclassified PIK3CG PI3-kinase p110-gamma subunit P48736 CHEMBL3267
Hydrolase ACHE Acetylcholinesterase P22303 CHEMBL220
Hydrolase GAA Lysosomal alpha-glucosidase P10253 CHEMBL2608
Isomerase TOP2A DNA topoisomerase II alpha P11388 CHEMBL1806
Lyase CA14 Carbonic anhydrase XIV Q9ULX7 CHEMBL3510
Lyase CA7 Carbonic anhydrase VII P43166 CHEMBL2326
Lyase CA3 Carbonic anhydrase III P07451 CHEMBL2885
Lyase CA5B Carbonic anhydrase VB Q9Y2D0 CHEMBL3969
Lyase CA5A Carbonic anhydrase VA P35218 CHEMBL4789
Lyase CA1 Carbonic anhydrase I P00915 CHEMBL261
Lyase CA9 Carbonic anhydrase IX Q16790 CHEMBL3594
Lyase CA13 Carbonic anhydrase XIII Q8N1Q1 CHEMBL3912
Lyase CA4 Carbonic anhydrase IV P22748 CHEMBL3729
Lyase CA6 Carbonic anhydrase VI P23280 CHEMBL3025
Lyase CA2 Carbonic anhydrase II P00918 CHEMBL205
Lyase CA12 Carbonic anhydrase XII O43570 CHEMBL3242
Lysine demethylase KDM4E Lysine-specific demethylase 4D-like B2RXH2 CHEMBL1293226
Metallo protease MMP13 Matrix metalloproteinase 13 P45452 CHEMBL280
Metallo protease MMP2 Matrix metalloproteinase-2 P08253 CHEMBL333
Metallo protease MMP3 Matrix metalloproteinase 3 P08254 CHEMBL283
Metallo protease MMP14 Matrix metalloproteinase 14 P50281 CHEMBL3869
Metallo protease MMP9 Matrix metalloproteinase 9 P14780 CHEMBL321
Methyl-lysine/arginine binding protein L3MBTL1 Lethal(3)malignant brain tumor-like protein 1 Q9Y468 CHEMBL1287622
Miscellaneous ion channel BCL2 Apoptosis regulator Bcl-2 P10415 CHEMBL4860
Nuclear hormone receptor subfamily 1 group C PPARA Peroxisome proliferator-activated receptor alpha Q07869 CHEMBL239
Nuclear hormone receptor subfamily 1 group C PPARG Peroxisome proliferator-activated receptor gamma P37231 CHEMBL235
Nuclear hormone receptor subfamily 1 group C PPARD Peroxisome proliferator-activated receptor delta Q03181 CHEMBL3979
Nuclear hormone receptor subfamily 1 group H NR1H3 LXR-alpha Q13133 CHEMBL2808
Nuclear hormone receptor subfamily 1 group I NR1I2 Pregnane X receptor O75469 CHEMBL3401
Nuclear hormone receptor subfamily 3 group B ESRRA Estrogen-related receptor alpha P11474 CHEMBL3429
Nuclear hormone receptor subfamily 3 group C AR Androgen Receptor P10275 CHEMBL1871
Oxidoreductase MAOA Monoamine oxidase A P21397 CHEMBL1951
Oxidoreductase PTGS1 Cyclooxygenase-1 P23219 CHEMBL221
Oxidoreductase ALOX5 Arachidonate 5-lipoxygenase P09917 CHEMBL215
Oxidoreductase TYR Tyrosinase P14679 CHEMBL1973
Oxidoreductase XDH Xanthine dehydrogenase P47989 CHEMBL1929
Peptide receptor (family A GPCR) TSHR Thyroid stimulating hormone receptor P16473 CHEMBL1963
Peptide receptor (family A GPCR) NPSR1 Neuropeptide S receptor Q6W5P4 CHEMBL5162
Peptide receptor (family A GPCR) CXCR1 Interleukin-8 receptor A P25024 CHEMBL4029
Peptide receptor (family A GPCR) NMUR2 Neuromedin-U receptor 2 Q9GZQ4 CHEMBL1075144
Protein Kinase IGF1R Insulin-like growth factor I receptor P08069 CHEMBL1957
Protein Kinase PTK2 Focal adhesion kinase 1 Q05397 CHEMBL2695
Protein Kinase BRAF Serine/threonine-protein kinase B-raf P15056 CHEMBL5145
Protein Kinase AURKB Serine/threonine-protein kinase Aurora-B Q96GD4 CHEMBL2185
Protein Kinase AURKA Serine/threonine-protein kinase Aurora-A O14965 CHEMBL4722
Protein Kinase DYRK1A Dual-specificity tyrosine-phosphorylation regulated kinase 1A Q13627 CHEMBL2292
Protein Kinase FLT4 Vascular endothelial growth factor receptor 3 P35916 CHEMBL1955
Protein Kinase EPHB4 Ephrin type-B receptor 4 P54760 CHEMBL5147
Protein Kinase MAP3K8 Mitogen-activated protein kinase kinase kinase 8 P41279 CHEMBL4899
Protein Kinase TEK Tyrosine-protein kinase TIE-2 Q02763 CHEMBL4128
Protein Kinase PDGFRB Platelet-derived growth factor receptor beta P09619 CHEMBL1913
Protein Kinase INSR Insulin receptor P06213 CHEMBL1981
Protein Kinase PLK4 Serine/threonine-protein kinase PLK4 O00444 CHEMBL3788
Protein Kinase CDK1 Cyclin-dependent kinase 1 P06493 CHEMBL308
Protein Kinase MAPK1 MAP kinase ERK2 P28482 CHEMBL4040
Protein Kinase MAPK14 MAP kinase p38 alpha Q16539 CHEMBL260
Protein Kinase ERBB2 Receptor protein-tyrosine kinase erbB-2 P04626 CHEMBL1824
Protein Kinase EGFR Epidermal growth factor receptor erbB1 P00533 CHEMBL203
Protein Kinase PIM1 Serine/threonine-protein kinase PIM1 P11309 CHEMBL2147
Protein Kinase NUAK1 NUAK family SNF1-like kinase 1 O60285 CHEMBL5784
Protein Kinase ALK ALK tyrosine kinase receptor Q9UM73 CHEMBL4247
Protein Kinase MYLK Myosin light chain kinase, smooth muscle Q15746 CHEMBL2428
Protein Kinase NEK2 Serine/threonine-protein kinase NEK2 P51955 CHEMBL3835
Protein Kinase KDR Vascular endothelial growth factor receptor 2 P35968 CHEMBL279
Protein Kinase PLK1 Serine/threonine-protein kinase PLK1 P53350 CHEMBL3024
Protein Kinase PKN1 Protein kinase N1 Q16512 CHEMBL3384
Protein Kinase NEK6 Serine/threonine-protein kinase NEK6 Q9HC98 CHEMBL4309
Protein Kinase AKT1 Serine/threonine-protein kinase AKT P31749 CHEMBL4282
Protein Kinase MET Hepatocyte growth factor receptor P08581 CHEMBL3717
Protein Kinase CAMK2B CaM kinase II beta Q13554 CHEMBL4121
Protein Kinase GSK3B Glycogen synthase kinase-3 beta P49841 CHEMBL262
Protein Kinase CSNK2A1 Casein kinase II alpha P68400 CHEMBL3629
Protein Kinase DAPK1 Death-associated protein kinase 1 P53355 CHEMBL2558
Protein Kinase SYK Tyrosine-protein kinase SYK P43405 CHEMBL2599
Protein Kinase AXL Tyrosine-protein kinase receptor UFO P30530 CHEMBL4895
Protein Kinase FLT3 Tyrosine-protein kinase receptor FLT3 P36888 CHEMBL1974
Protein Kinase SRC Tyrosine-protein kinase SRC P12931 CHEMBL267
Protein Phosphatase DUSP3 Dual specificity protein phosphatase 3 P51452 CHEMBL2635
Serine protease F10 Coagulation factor X P00742 CHEMBL244
Serine protease F2 Thrombin P00734 CHEMBL204
SLC superfamily of solute carriers SLC22A6 Solute carrier family 22 member 6 Q4U2R8 CHEMBL1641347
SLC superfamily of solute carriers SLCO1B1 Solute carrier organic anion transporter family member 1B1 Q9Y6L6 CHEMBL1697668
SLC superfamily of solute carriers SLCO1B3 Solute carrier organic anion transporter family member 1B3 Q9NPD5 CHEMBL1743121
Small molecule receptor (family A GPCR) GPR35 G-protein coupled receptor 35 Q9HC97 CHEMBL1293267
Small molecule receptor (family A GPCR) FFAR1 Free fatty acid receptor 1 O14842 CHEMBL4422
Small molecule receptor (family A GPCR) FFAR4 G-protein coupled receptor 120 Q5NUL3 CHEMBL5339
Small molecule receptor (family A GPCR) DRD4 Dopamine D4 receptor P21917 CHEMBL219
Small molecule receptor (family A GPCR) ADRA2C Alpha-2c adrenergic receptor P18825 CHEMBL1916
Small molecule receptor (family A GPCR) ADRA2A Alpha-2a adrenergic receptor P08913 CHEMBL1867
Toll-like and Il-1 receptors TLR2 Toll-like receptor 2 O60603 CHEMBL4163
Transcription Factor AHR Aryl hydrocarbon receptor P35869 CHEMBL3201
Transcription Factor STAT6 Signal transducer and activator of transcription 6 P42226 CHEMBL5401
Transcription Factor HIF1A Hypoxia-inducible factor 1 alpha Q16665 CHEMBL4261
Transcription Factor NFKB1 Nuclear factor NF-kappa-B p105 subunit P19838 CHEMBL3251
Transcription Factor TP53 Cellular tumor antigen p53 P04637 CHEMBL4096
Transferase FUT7 Alpha-(1,3)-fucosyltransferase 7 Q11130 CHEMBL3596077
Unclassified SMAD3 Mothers against decapentaplegic homolog 3 P84022 CHEMBL1293258
Unclassified LMNA Prelamin-A/C P02545 CHEMBL1293235
Unclassified FABP4 Fatty acid binding protein adipocyte P15090 CHEMBL2083
Unclassified MAPT Microtubule-associated protein tau P10636 CHEMBL1293224
Unclassified FABP3 Fatty acid binding protein muscle P05413 CHEMBL3344
Unclassified FABP5 Fatty acid binding protein epidermal Q01469 CHEMBL3674
Unclassified HBB Hemoglobin beta chain P68871 CHEMBL4331
Unclassified THPO Thrombopoietin P40225 CHEMBL1293256
Unclassified HTT Huntingtin P42858 CHEMBL5514
Unclassified FABP2 Fatty acid binding protein intestinal P12104 CHEMBL4879
Unclassified APP Beta amyloid A4 protein P05067 CHEMBL2487
Unclassified HSPA1A Heat shock 70 kDa protein 1 P0DMV8 CHEMBL5460
Enrichment of Gene Ontology of Target Proteins (Activity≤10μM)


Detailed Information of Enriched Gene Ontolgy
GO Type GO Category Enriched GO Terms p-Value Adjusted p-Value Enriched Genes
MF GO:0005488; binding GO:0008270; zinc ion binding 8.286E-13 1.236E-10 APOBEC3G, AR, BLM, CA1, CA12, CA13, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DNMT1, ESRRA, GLO1, L3MBTL1, MMP13, MMP14, MMP2, MMP3, MMP9, NR1H3, NR1I2, PPARA, PPARD, PPARG, SMAD3, TP53
MF GO:0005488; binding GO:0019825; oxygen binding 1.489E-12 2.105E-10 CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C8, CYP2C9, CYP3A4, HBB, NOX4
BP GO:0009987; cellular process GO:0051897; positive regulation of protein kinase B signaling 1.362E-11 1.666E-09 AXL, EGFR, ERBB2, F10, INSR, MET, NOX4, PDGFRB, PIK3CG, PIK3R1, PTK2, SRC, TEK, THPO
MF GO:0005488; binding GO:0020037; heme binding 2.172E-11 2.529E-09 CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C8, CYP2C9, CYP3A4, HBB, MPO, NOX4, PTGS1, SRC
BP GO:0008152; metabolic process GO:0097267; omega-hydroxylase P450 pathway 4.060E-11 4.569E-09 CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C8, CYP2C9
BP GO:0050896; response to stimulus GO:0042738; exogenous drug catabolic process 1.764E-10 1.855E-08 CYP1A2, CYP2C19, CYP2C8, CYP2C9, CYP3A4, NR1I2
MF GO:0005488; binding GO:0005506; iron ion binding 3.639E-10 3.720E-08 ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C8, CYP2C9, CYP3A4, HBB, XDH
CC GO:0016020; membrane GO:0016323; basolateral plasma membrane 2.330E-09 2.123E-07 ABCC1, ADRA2A, CA2, CA4, CA9, EGFR, ERBB2, HPGD, SLC22A6, SLCO1B1, SLCO1B3, TEK, TSHR
BP Unclassified; GO:0032846; positive regulation of homeostatic process 2.647E-09 2.402E-07 AURKB, CA2, CA7, EGFR, F2, HIF1A, HTT, MAPK1, MAPK14, NEK2, NPSR1, NR1H3, PLA2G1B, SYK
MF Unclassified; GO:0004716; signal transducer, downstream of receptor, with protein tyrosine kinase activity 3.246E-09 2.878E-07 EGFR, ERBB2, INSR, KDR, SYK
MF GO:0003824; catalytic activity GO:0034875; caffeine oxidase activity 3.494E-09 3.031E-07 CYP1A2, CYP2C8, CYP2C9, CYP3A4
MF GO:0140110; transcription regulator activity GO:0004879; nuclear receptor activity 3.776E-09 3.239E-07 AHR, AR, ESRRA, NR1H3, NR1I2, PPARA, PPARD, PPARG
BP GO:0008152; metabolic process GO:0019373; epoxygenase P450 pathway 9.776E-09 7.769E-07 CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C8, CYP2C9
MF GO:0005488; binding GO:0046982; protein heterodimerization activity 1.100E-08 8.649E-07 ADRA2A, ADRA2C, AHR, AURKA, AXL, BCL2, BRAF, EGFR, ERBB2, HIF1A, NFKB1, PIK3R1, PPARD, PPARG, SMAD3, TLR2, TOP2A, TP53, TYR
MF GO:0003824; catalytic activity GO:0070330; aromatase activity 1.796E-08 1.367E-06 CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C8, CYP3A4
BP GO:0050896; response to stimulus GO:0050728; negative regulation of inflammatory response 2.191E-08 1.634E-06 CYP19A1, F2, FFAR4, NFKB1, NR1H3, PPARA, PPARD, PPARG, SMAD3, TEK
MF Unclassified; GO:0004872; receptor activity 2.512E-08 1.848E-06 ADRA2A, ADRA2C, AHR, ALK, AR, AXL, CXCR1, DRD4, EGFR, EPHB4, ERBB2, ESRRA, F2, FFAR1, FFAR4, FLT3, FLT4, GPR35, HPGD, IGF1R, INSR, KDR, MET, NMUR2, NPSR1, NR1H3, NR1I2, PDGFRB, PPARA, PPARD, PPARG, TEK, TLR2, TSHR
BP Unclassified; GO:0032844; regulation of homeostatic process 3.154E-08 2.282E-06 ADRA2A, AURKB, BCL2, CA2, CA7, EGFR, F2, HIF1A, HTT, KDR, MAPK1, MAPK14, NEK2, NPSR1, NR1H3, PLA2G1B, SRC, SYK
BP GO:0009987; cellular process GO:0070374; positive regulation of ERK1 and ERK2 cascade 4.571E-08 3.211E-06 ALOX15, APP, BRAF, EGFR, FFAR4, FLT4, KDR, NOX4, PDGFRB, SRC, TEK, THPO
BP GO:0008152; metabolic process GO:0016098; monoterpenoid metabolic process 5.178E-08 3.602E-06 CYP1A2, CYP2C19, CYP2C9, CYP3A4
CC GO:0044464; cell part GO:0005829; cytosol 6.638E-08 4.489E-06 AHR, AKR1B1, AKT1, ALDH1A1, ALOX12, ALOX15, ALOX5, APOBEC3G, APP, AR, AURKA, AURKB, BCL2, BLM, BRAF, CA1, CA13, CA2, CA3, CA7, CAMK2B, CDK1, CSNK2A1, DUSP3, EPHB4, ERBB2, FABP2, FABP3, FABP4, FABP5, FLT3, GLO1, GSK3B, HBB, HIF1A, HPGD, HSD17B1, HSPA1A, HTT, LMNA, MAP3K8, MAPK1, MAPK14, MAPT, MMP14, MYLK, NEK2, NEK6, NFKB1, PGD, PIK3CG, PIK3R1, PIM1, PKM, PKN1, PLA2G1B, PLK1, PLK4, PPARG, PTK2, PYGL, SMAD3, SRC, STAT6, SYK, TP53, TYR, XDH
BP GO:0051179; localization GO:0042307; positive regulation of protein import into nucleus 7.053E-08 4.726E-06 APP, CDK1, EGFR, F2, MAPK1, MAPK14, PIK3R1, SMAD3, TLR2
BP GO:0008152; metabolic process GO:0038083; peptidyl-tyrosine autophosphorylation 7.174E-08 4.777E-06 EGFR, IGF1R, INSR, KDR, PTK2, SRC, SYK
CC GO:0043226; organelle GO:0005654; nucleoplasm 1.858E-07 1.136E-05 AHR, AKR1B1, AKT1, ALOX5, APEX1, AR, AURKA, AURKB, BCL2, BLM, CAMK2B, CDK1, CSNK2A1, CTDSP1, DNMT1, DUSP3, DYRK1A, ESRRA, FABP5, GSK3B, HIF1A, HPGD, HSPA1A, HTT, L3MBTL1, LMNA, MAPK1, MAPK14, NEK2, NEK6, NFKB1, NR1H3, NR1I2, NUAK1, PIM1, PKN1, PLK1, POLB, PPARA, PPARD, PPARG, RECQL, SMAD3, SRC, STAT6, TERT, TOP2A, TP53, USP2
CC GO:0032991; macromolecular complex GO:0043235; receptor complex 2.255E-07 1.368E-05 ABCG2, ADRA2A, AHR, APP, EGFR, ERBB2, FLT4, IGF1R, INSR, NR1H3, SMAD3, SYK, TLR2, TSHR
MF GO:0060089; molecular transducer activity GO:0003707; steroid hormone receptor activity 3.600E-07 2.102E-05 AR, ESRRA, NR1H3, NR1I2, PPARA, PPARD, PPARG
BP GO:0032501; multicellular organismal process GO:0051241; negative regulation of multicellular organismal process 3.798E-07 2.194E-05 ADRA2C, ALOX12, APP, AXL, BCL2, CTDSP1, EGFR, ERBB2, F2, FFAR4, GPR35, GSK3B, HIF1A, LMNA, NFKB1, NR1H3, PIK3CG, PIK3R1, PPARD, PPARG, PTK2, SMAD3, TEK, TERT, TLR2, XDH
BP GO:0050896; response to stimulus GO:0055093; response to hyperoxia 4.862E-07 2.750E-05 CYP1A1, PDGFRB, POLB, PPARG, TP53
BP GO:0051179; localization GO:0042908; xenobiotic transport 7.075E-07 3.861E-05 ABCB1, ABCC1, ABCG2, NR1I2
BP GO:0009987; cellular process GO:0014068; positive regulation of phosphatidylinositol 3-kinase signaling 7.855E-07 4.255E-05 F2, FLT3, KDR, PDGFRB, PPARD, PTK2, TEK
MF GO:0003824; catalytic activity GO:0004712; protein serine/threonine/tyrosine kinase activity 8.263E-07 4.443E-05 AKT1, AURKA, AURKB, DYRK1A, MAPK1, MAPK14
MF GO:0005488; binding GO:0042803; protein homodimerization activity 9.196E-07 4.872E-05 ABCG2, ACHE, ADRA2A, ADRA2C, AKT1, APOBEC3G, BCL2, BLM, CAMK2B, FLT3, FLT4, HPGD, MAPT, NFKB1, PYGL, SLC22A6, SMAD3, TERT, TOP2A, TYR, XDH
BP GO:0009987; cellular process GO:0030522; intracellular receptor signaling pathway 1.130E-06 5.788E-05 AHR, AR, ESRRA, NR1H3, NR1I2, PIM1, PPARA, PPARD, PPARG, SRC
BP GO:0009987; cellular process GO:1901796; regulation of signal transduction by p53 class mediator 1.190E-06 6.068E-05 AKT1, AURKA, AURKB, BLM, CSNK2A1, DYRK1A, L3MBTL1, MAPK14, NUAK1, TP53
BP GO:0009987; cellular process GO:0048010; vascular endothelial growth factor receptor signaling pathway 1.429E-06 7.220E-05 AXL, FLT4, KDR, MAPK14, PIK3R1, PTK2, SRC
BP GO:0009987; cellular process GO:0071456; cellular response to hypoxia 1.505E-06 7.568E-05 AKT1, BCL2, HIF1A, LMNA, PPARD, SRC, TERT, TP53
BP GO:0008152; metabolic process GO:0070989; oxidative demethylation 1.648E-06 8.191E-05 CYP1A2, CYP2C8, CYP2C9, CYP3A4
BP GO:0065007; biological regulation GO:0000187; activation of MAPK activity 1.777E-06 8.754E-05 ALK, CDK1, DRD4, INSR, MAPK1, MAPK14, PKN1, PLA2G1B, SYK
MF GO:0005488; binding GO:0043548; phosphatidylinositol 3-kinase binding 2.699E-06 1.258E-04 AXL, IGF1R, INSR, PDGFRB, PIK3R1
BP GO:0008152; metabolic process GO:0043552; positive regulation of phosphatidylinositol 3-kinase activity 3.218E-06 1.472E-04 FLT3, PDGFRB, PTK2, SRC, TEK
MF Unclassified; GO:0032403; protein complex binding 3.589E-06 1.628E-04 ACHE, ADRA2A, APEX1, EGFR, FLT3, IGF1R, INSR, KDR, MMP13, MMP14, MMP9, PIK3R1, PKM, PLK1, PPARA, SMAD3, SRC, SYK, TLR2, TSHR
BP GO:0009987; cellular process GO:0071276; cellular response to cadmium ion 3.813E-06 1.709E-04 AKT1, CYP1A2, EGFR, MAPK1, MMP9
BP GO:0065007; biological regulation GO:0031647; regulation of protein stability 4.032E-06 1.788E-04 AURKA, BCL2, HSPA1A, HTT, MAPK1, PIK3R1, PLK1, SMAD3, SRC, TERT, USP2
BP GO:0065007; biological regulation GO:0042593; glucose homeostasis 4.266E-06 1.880E-04 ADRA2A, AKT1, FFAR1, HIF1A, INSR, NOX4, PIK3R1, PPARG, PYGL
BP GO:0009987; cellular process GO:0038084; vascular endothelial growth factor signaling pathway 4.462E-06 1.947E-04 FLT3, FLT4, KDR, PDGFRB
MF GO:0005488; binding GO:0051879; Hsp90 protein binding 4.491E-06 1.956E-04 AHR, CSNK2A1, HIF1A, KDR, MAPT
MF GO:0003824; catalytic activity GO:0101020; estrogen 16-alpha-hydroxylase activity 4.538E-06 1.961E-04 CYP1A1, CYP2C8, CYP3A4
MF GO:0003824; catalytic activity GO:0004556; alpha-amylase activity 4.538E-06 1.961E-04 AMY1A, AMY1B, AMY1C
MF Unclassified; GO:0103025; alpha-amylase activity (releasing maltohexaose) 4.538E-06 1.961E-04 AMY1A, AMY1B, AMY1C
BP GO:0008152; metabolic process GO:0019372; lipoxygenase pathway 5.913E-06 2.505E-04 ALOX12, ALOX15, ALOX5, HPGD
BP GO:0065007; biological regulation GO:0032148; activation of protein kinase B activity 6.129E-06 2.586E-04 ADRA2A, ADRA2C, AKT1, INSR, SRC
BP GO:0009987; cellular process GO:0070301; cellular response to hydrogen peroxide 7.747E-06 3.189E-04 AKR1B1, APEX1, AXL, CDK1, CYP1B1, STAT6
BP GO:0009987; cellular process GO:0043401; steroid hormone mediated signaling pathway 8.008E-06 3.284E-04 AR, ESRRA, NR1H3, NR1I2, PPARA, PPARD, PPARG, SRC
MF GO:0005488; binding GO:0019838; growth factor binding 8.008E-06 3.284E-04 EGFR, ERBB2, FLT4, IGF1R, INSR, KDR, PDGFRB, TEK
BP GO:0040011; locomotion GO:0014911; positive regulation of smooth muscle cell migration 8.201E-06 3.350E-04 BCL2, NOX4, PDGFRB, SRC, TERT
BP GO:0051179; localization GO:0010887; negative regulation of cholesterol storage 9.025E-06 3.632E-04 NR1H3, PPARA, PPARG
BP GO:0008152; metabolic process GO:0002933; lipid hydroxylation 9.025E-06 3.632E-04 CYP1A1, CYP2C8, CYP3A4
BP GO:0048511; rhythmic process GO:0042752; regulation of circadian rhythm 1.134E-05 4.458E-04 DRD4, NR1H3, PPARA, PPARG, TOP2A, TP53, USP2
BP GO:0050896; response to stimulus GO:0032103; positive regulation of response to external stimulus 1.184E-05 4.630E-04 BRAF, EGFR, F2, FABP4, KDR, MAPK14, MET, PDGFRB, PIK3CG, SMAD3, TLR2
MF GO:0003824; catalytic activity GO:0046934; phosphatidylinositol-4,5-bisphosphate 3-kinase activity 1.228E-05 4.783E-04 EGFR, ERBB2, MET, PDGFRB, PIK3CG, PIK3R1
MF Unclassified; GO:0099600; transmembrane receptor activity 1.238E-05 4.805E-04 ADRA2A, ADRA2C, ALK, AXL, CXCR1, DRD4, EGFR, EPHB4, ERBB2, FFAR1, FFAR4, FLT3, FLT4, GPR35, HPGD, IGF1R, INSR, KDR, MET, NMUR2, NPSR1, PDGFRB, PPARG, TEK, TSHR
BP GO:0009987; cellular process GO:0050714; positive regulation of protein secretion 1.552E-05 5.928E-04 ACHE, EGFR, FFAR1, HIF1A, MAPK14, PLA2G1B, PPARD, SRC, SYK, TLR2
BP GO:0008152; metabolic process GO:0045429; positive regulation of nitric oxide biosynthetic process 1.580E-05 5.973E-04 AKT1, EGFR, HBB, INSR, SMAD3
MF GO:0060089; molecular transducer activity GO:0005021; vascular endothelial growth factor-activated receptor activity 1.570E-05 5.973E-04 FLT3, FLT4, KDR
MF GO:0005215; transporter activity GO:0008559; xenobiotic transmembrane transporting ATPase activity 1.570E-05 5.973E-04 ABCB1, ABCC1, ABCG2
MF GO:0005488; binding GO:0002039; p53 binding 1.727E-05 6.451E-04 BLM, GSK3B, HIF1A, HTT, NUAK1, TP53
CC GO:0016020; membrane GO:0045121; membrane raft 1.868E-05 6.941E-04 APP, BACE1, EGFR, INSR, KDR, MAPK1, SLC22A6, SRC, STAT6, TEK, TLR2
BP Unclassified; GO:0044236; multicellular organism metabolic process 1.897E-05 7.027E-04 HIF1A, MMP13, MMP14, MMP2, MMP3, MMP9, PLA2G1B
BP GO:0051179; localization GO:0046326; positive regulation of glucose import 2.004E-05 7.385E-04 AKT1, INSR, MAPK14, PIK3R1, TERT
BP Unclassified; GO:0044243; multicellular organismal catabolic process 2.200E-05 7.984E-04 MMP13, MMP14, MMP2, MMP3, MMP9, PLA2G1B
BP GO:0050896; response to stimulus GO:0043627; response to estrogen 2.200E-05 7.984E-04 CA2, MAPK1, MMP14, PDGFRB, PPARG, TEK
BP GO:0008283; cell proliferation GO:1904707; positive regulation of vascular smooth muscle cell proliferation 2.292E-05 8.235E-04 HPGD, MMP2, MMP9, TERT
BP GO:0008152; metabolic process GO:1902895; positive regulation of pri-miRNA transcription from RNA polymerase II promoter 2.292E-05 8.235E-04 HIF1A, SMAD3, TERT, TP53
BP GO:0002376; immune system process GO:0043312; neutrophil degranulation 2.436E-05 8.652E-04 ALOX5, CXCR1, FABP5, GAA, HBB, HSPA1A, MAPK1, MAPK14, MMP9, MPO, NFKB1, PKM, PYGL, TLR2
MF GO:0005488; binding GO:0051379; epinephrine binding 2.498E-05 8.845E-04 ADRA2A, ADRA2C, DRD4
BP GO:0009987; cellular process GO:0070507; regulation of microtubule cytoskeleton organization 3.457E-05 1.180E-03 AURKA, GSK3B, HSPA1A, MAPT, MET, NEK2, PLK1, PLK4
BP GO:0008152; metabolic process GO:0006367; transcription initiation from RNA polymerase II promoter 3.616E-05 1.226E-03 AR, CDK1, ESRRA, NR1H3, NR1I2, PPARA, PPARD, PPARG
BP Unclassified; GO:2000021; regulation of ion homeostasis 3.666E-05 1.242E-03 BCL2, CA2, CA7, F2, HTT, KDR, NPSR1, PLA2G1B, SRC
BP GO:0050896; response to stimulus GO:0070542; response to fatty acid 3.714E-05 1.250E-03 AKT1, FABP3, FFAR1, PPARG, SRC, TLR2
BP GO:0032501; multicellular organismal process GO:0048143; astrocyte activation 3.726E-05 1.250E-03 APP, EGFR, MAPT
BP GO:0009987; cellular process GO:0000733; DNA strand renaturation 3.726E-05 1.250E-03 BLM, RECQL, TP53
CC GO:0044421; extracellular region part GO:0070062; extracellular exosome 3.857E-05 1.288E-03 ABCB1, ABCC1, AKR1B1, ALDH1A1, ALK, ALOX12, AMY1A, AMY1B, AMY1C, APP, AXL, CA1, CA2, CA4, CA6, CDK1, CTDSP1, DUSP3, EPHB4, F2, FABP3, FABP4, FABP5, GAA, GLO1, HBB, HPGD, HSPA1A, INSR, MAPK1, MAPK14, MMP9, MPO, MYLK, PDGFRB, PGD, PKM, PTGS1, PYGL, SLC22A6, SRC
BP GO:0008152; metabolic process GO:0019433; triglyceride catabolic process 3.892E-05 1.298E-03 FABP2, FABP3, FABP4, FABP5
BP GO:0050896; response to stimulus GO:1901655; cellular response to ketone 3.986E-05 1.323E-03 AKR1B1, AKT1, AR, EGFR, PPARG, SRC
CC GO:0044425; membrane part GO:0005887; integral component of plasma membrane 4.164E-05 1.374E-03 ABCC1, ADRA2A, ADRA2C, ALK, APP, AXL, BACE1, DRD4, EPHB4, FFAR1, FFAR4, FLT3, FLT4, GPR35, IGF1R, INSR, KDR, MET, MMP14, NPSR1, SLC22A6, SLCO1B1, SLCO1B3, TEK, TLR2, TSHR
BP GO:0023052; signaling GO:0050806; positive regulation of synaptic transmission 4.462E-05 1.463E-03 APP, BRAF, CA2, CA7, DRD4, EGFR, MAPK1
BP GO:0051179; localization GO:2001225; regulation of chloride transport 5.292E-05 1.707E-03 ABCB1, CA2, CA7
BP GO:0008152; metabolic process GO:0051974; negative regulation of telomerase activity 5.292E-05 1.707E-03 PPARG, SRC, TP53
BP Unclassified; GO:0044259; multicellular organismal macromolecule metabolic process 5.594E-05 1.796E-03 HIF1A, MMP13, MMP14, MMP2, MMP3, MMP9
CC GO:0043226; organelle GO:0005876; spindle microtubule 5.614E-05 1.798E-03 AURKA, AURKB, CDK1, PLK1, POLB
BP GO:0065007; biological regulation GO:0043006; activation of phospholipase A2 activity by calcium-mediated signaling 5.991E-05 1.899E-03 EGFR, NMUR2
BP GO:0009987; cellular process GO:0006286; base-excision repair, base-free sugar-phosphate removal 5.991E-05 1.899E-03 APEX1, POLB
BP GO:0008152; metabolic process GO:2001303; lipoxin A4 biosynthetic process 5.991E-05 1.899E-03 ALOX12, ALOX15
MF GO:0003824; catalytic activity GO:0047977; hepoxilin-epoxide hydrolase activity 5.991E-05 1.899E-03 ALOX12, ALOX15
MF GO:0005488; binding GO:0043621; protein self-association 6.148E-05 1.935E-03 ACHE, DYRK1A, FLT3, PPARG, TP53
BP GO:0008152; metabolic process GO:0046320; regulation of fatty acid oxidation 6.187E-05 1.938E-03 AKT1, FABP3, PPARA, PPARG
BP GO:0008152; metabolic process GO:0016572; histone phosphorylation 6.187E-05 1.938E-03 AURKA, AURKB, CDK1, PKN1
MF GO:0005488; binding GO:0051721; protein phosphatase 2A binding 6.187E-05 1.938E-03 AKT1, BCL2, MAPT, TP53
BP GO:0065007; biological regulation GO:0010952; positive regulation of peptidase activity 6.551E-05 2.029E-03 APP, DAPK1, MAPK14, MAPT, MMP14, PPARG, SMAD3, XDH
BP GO:0008152; metabolic process GO:0045740; positive regulation of DNA replication 6.721E-05 2.073E-03 CDK1, EGFR, IGF1R, INSR, PLA2G1B
CC GO:0043226; organelle GO:0044454; nuclear chromosome part 7.088E-05 2.174E-03 APEX1, AR, AURKA, AURKB, BLM, CDK1, CSNK2A1, NR1H3, PLK1, PPARD, SMAD3, STAT6, TERT, TP53
MF GO:0005488; binding GO:0043560; insulin receptor substrate binding 7.236E-05 2.207E-03 IGF1R, INSR, PIK3R1
MF GO:0005488; binding GO:0034452; dynactin binding 7.236E-05 2.207E-03 GSK3B, HTT, MAPT
BP GO:0032502; developmental process GO:0002009; morphogenesis of an epithelium 7.285E-05 2.218E-03 AR, BCL2, CA2, CA9, EGFR, HIF1A, MET, MMP14, SMAD3, SRC
BP GO:0050896; response to stimulus GO:0031663; lipopolysaccharide-mediated signaling pathway 9.337E-05 2.759E-03 AKT1, MAPK1, MAPK14, TLR2
CC GO:0043226; organelle GO:0051233; spindle midzone 9.337E-05 2.759E-03 APP, AURKA, AURKB, PLK1
BP GO:0009987; cellular process GO:2001243; negative regulation of intrinsic apoptotic signaling pathway 9.765E-05 2.858E-03 AKT1, BCL2, HIF1A, HSPA1A, MMP9, SRC
BP GO:0009987; cellular process GO:1901215; negative regulation of neuron death 1.044E-04 3.040E-03 AKT1, AXL, BCL2, BRAF, GSK3B, HIF1A, PPARA, TERT
BP GO:0032501; multicellular organismal process GO:0003007; heart morphogenesis 1.061E-04 3.071E-03 EPHB4, GAA, INSR, PTK2
BP GO:0065007; biological regulation GO:0051092; positive regulation of NF-kappaB transcription factor activity 1.123E-04 3.226E-03 ALK, APP, AR, HSPA1A, NFKB1, PLA2G1B, TLR2
BP GO:0008152; metabolic process GO:0010907; positive regulation of glucose metabolic process 1.200E-04 3.424E-03 AKT1, INSR, PPARA, SRC
BP GO:0051179; localization GO:1903169; regulation of calcium ion transmembrane transport 1.227E-04 3.489E-03 ADRA2A, DRD4, F2, GPR35, HTT, NPSR1, PIK3CG
BP GO:0008152; metabolic process GO:0046854; phosphatidylinositol phosphorylation 1.227E-04 3.489E-03 EGFR, ERBB2, MET, PDGFRB, PIK3CG, PIK3R1
BP GO:0008152; metabolic process GO:0006703; estrogen biosynthetic process 1.240E-04 3.506E-03 CYP19A1, HSD17B1, HSD17B2
BP GO:0009987; cellular process GO:0010745; negative regulation of macrophage derived foam cell differentiation 1.240E-04 3.506E-03 NR1H3, PPARA, PPARG
BP GO:0032501; multicellular organismal process GO:0045685; regulation of glial cell differentiation 1.292E-04 3.621E-03 APP, CDK1, F2, PPARG, TLR2
BP GO:0009987; cellular process GO:2001240; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand 1.352E-04 3.763E-03 AKT1, BCL2, HSPA1A, TERT
BP GO:0050896; response to stimulus GO:0009612; response to mechanical stimulus 1.447E-04 4.000E-03 AKT1, EGFR, MAPK14, MMP14, MPO, NFKB1, PPARG, SRC
MF GO:0005488; binding GO:0003682; chromatin binding 1.489E-04 4.109E-03 APEX1, AR, CDK1, DNMT1, EGFR, L3MBTL1, MPO, NFKB1, PKN1, PPARG, SMAD3, TOP2A, TP53
BP GO:0008152; metabolic process GO:0030574; collagen catabolic process 1.499E-04 4.128E-03 MMP13, MMP14, MMP2, MMP3, MMP9
CC GO:0044464; cell part GO:0048471; perinuclear region of cytoplasm 1.588E-04 4.328E-03 ACHE, AKR1B1, APEX1, APP, AURKA, CA4, EGFR, ERBB2, HSPA1A, HTT, NOX4, PPARG, SRC, TYR, USP2
BP GO:0009987; cellular process GO:0010389; regulation of G2/M transition of mitotic cell cycle 1.607E-04 4.370E-03 APP, AURKA, AURKB, BLM, CDK1, NEK2, PLK1, PLK4
BP GO:0032501; multicellular organismal process GO:0014005; microglia development 1.788E-04 4.789E-03 APP, TLR2
BP GO:0051179; localization GO:0099039; sphingolipid translocation 1.788E-04 4.789E-03 ABCB1, ABCC1
BP GO:0009987; cellular process GO:0032849; positive regulation of cellular pH reduction 1.788E-04 4.789E-03 CA2, CA7
MF GO:0003824; catalytic activity GO:0070576; vitamin D 24-hydroxylase activity 1.788E-04 4.789E-03 CYP1A1, CYP3A4
MF GO:0003824; catalytic activity GO:0004052; arachidonate 12-lipoxygenase activity 1.788E-04 4.789E-03 ALOX12, ALOX15
MF GO:0060089; molecular transducer activity GO:0004938; alpha2-adrenergic receptor activity 1.788E-04 4.789E-03 ADRA2A, ADRA2C
MF GO:0003824; catalytic activity GO:0051120; hepoxilin A3 synthase activity 1.788E-04 4.789E-03 ALOX12, ALOX15
BP GO:0050896; response to stimulus GO:0034405; response to fluid shear stress 1.890E-04 5.029E-03 AKT1, CA2, PDGFRB, SRC
BP GO:0009987; cellular process GO:0045742; positive regulation of epidermal growth factor receptor signaling pathway 1.890E-04 5.029E-03 ADRA2A, ADRA2C, AKT1, MMP9
BP GO:0032501; multicellular organismal process GO:0045780; positive regulation of bone resorption 1.950E-04 5.166E-03 CA2, EGFR, SYK
BP GO:0051179; localization GO:1905477; positive regulation of protein localization to membrane 2.298E-04 5.993E-03 AKT1, BCL2, EGFR, ERBB2, PIK3R1, TP53
BP GO:0009987; cellular process GO:0038128; ERBB2 signaling pathway 2.326E-04 6.037E-03 EGFR, ERBB2, PIK3R1, SRC
BP GO:0008152; metabolic process GO:0032965; regulation of collagen biosynthetic process 2.326E-04 6.037E-03 F2, PDGFRB, PPARD, PPARG
BP GO:0009987; cellular process GO:2000811; negative regulation of anoikis 2.387E-04 6.165E-03 BCL2, PTK2, SRC
BP GO:0032501; multicellular organismal process GO:0048546; digestive tract morphogenesis 2.387E-04 6.165E-03 BCL2, EGFR, HIF1A
BP GO:0065007; biological regulation GO:0060249; anatomical structure homeostasis 2.452E-04 6.325E-03 AKR1B1, APEX1, BCL2, BLM, GAA, HIF1A, NOX4, SRC, TERT
BP GO:0022610; biological adhesion GO:0033628; regulation of cell adhesion mediated by integrin 2.569E-04 6.595E-03 CYP1B1, PIK3CG, PTK2, SYK
BP GO:0009987; cellular process GO:1903201; regulation of oxidative stress-induced cell death 2.765E-04 7.067E-03 AKT1, HIF1A, MET, MMP3, TP53
BP GO:0050896; response to stimulus GO:0033189; response to vitamin A 2.882E-04 7.279E-03 CYP1A1, PPARD, PPARG
BP GO:0065007; biological regulation GO:1904355; positive regulation of telomere capping 2.882E-04 7.279E-03 AURKB, MAPK1, NEK2
MF GO:0003824; catalytic activity GO:0008392; arachidonic acid epoxygenase activity 2.882E-04 7.279E-03 CYP2C19, CYP2C8, CYP2C9
MF GO:0005488; binding GO:0001085; RNA polymerase II transcription factor binding 2.918E-04 7.353E-03 AHR, AR, GSK3B, PPARA, SMAD3, TP53
CC GO:0044464; cell part GO:0009986; cell surface 3.192E-04 7.953E-03 ABCB1, ACHE, APP, AXL, BACE1, CA4, EGFR, MET, PDGFRB, PLA2G1B, TEK, TLR2, TSHR
BP GO:0032502; developmental process GO:0048538; thymus development 3.407E-04 8.430E-03 BCL2, BRAF, MAPK1, TYR
BP GO:0008152; metabolic process GO:0051000; positive regulation of nitric-oxide synthase activity 3.438E-04 8.479E-03 AKT1, HIF1A, TERT
BP GO:0008152; metabolic process GO:0032928; regulation of superoxide anion generation 3.438E-04 8.479E-03 EGFR, MAPT, SYK
BP GO:0009987; cellular process GO:1900034; regulation of cellular response to heat 3.535E-04 8.656E-03 CAMK2B, GSK3B, HSPA1A, MAPK1, MAPT
BP GO:0008152; metabolic process GO:0018958; phenol-containing compound metabolic process 3.535E-04 8.656E-03 AKR1B1, BCL2, DRD4, MAOA, TYR
BP GO:0065007; biological regulation GO:0035625; epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway 3.558E-04 8.656E-03 ADRA2A, ADRA2C
BP GO:0009987; cellular process GO:0032811; negative regulation of epinephrine secretion 3.558E-04 8.656E-03 ADRA2A, ADRA2C
BP GO:0032501; multicellular organismal process GO:0032640; tumor necrosis factor production 3.558E-04 8.656E-03 APP, TLR2
BP GO:0008152; metabolic process GO:0018894; dibenzo-p-dioxin metabolic process 3.558E-04 8.656E-03 CYP1A1, CYP1A2
MF GO:0005488; binding GO:0051425; PTB domain binding 3.558E-04 8.656E-03 APP, INSR
MF GO:0005488; binding GO:0005497; androgen binding 3.558E-04 8.656E-03 ALDH1A1, AR
BP GO:0032501; multicellular organismal process GO:1903708; positive regulation of hemopoiesis 3.703E-04 8.963E-03 AXL, CA2, HIF1A, MAPK14, MMP14, SYK, THPO
BP GO:0032501; multicellular organismal process GO:0043536; positive regulation of blood vessel endothelial cell migration 3.725E-04 8.963E-03 AKT1, HIF1A, KDR, MAPK14
BP GO:0009987; cellular process GO:0007077; mitotic nuclear envelope disassembly 3.725E-04 8.963E-03 CDK1, LMNA, NEK6, PLK1
BP GO:0009987; cellular process GO:0022617; extracellular matrix disassembly 3.750E-04 9.014E-03 MMP13, MMP14, MMP2, MMP3, MMP9
BP GO:0009987; cellular process GO:0031334; positive regulation of protein complex assembly 3.816E-04 9.162E-03 ALOX15, GSK3B, HSPA1A, MAPT, MET, MMP3, SRC, TP53
BP GO:0009987; cellular process GO:0090199; regulation of release of cytochrome c from mitochondria 4.064E-04 9.650E-03 AKT1, LMNA, MMP9, TP53
BP GO:0008152; metabolic process GO:0032436; positive regulation of proteasomal ubiquitin-dependent protein catabolic process 4.211E-04 9.956E-03 AKT1, AURKA, GSK3B, HSPA1A, PLK1
MF GO:0003824; catalytic activity GO:0004089; carbonate dehydratase activity 1.370E-23 2.486E-20 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9
MF GO:0005488; binding GO:0005524; ATP binding 2.708E-18 1.255E-15 ABCB1, ABCC1, ABCG2, AKT1, ALK, AURKA, AURKB, AXL, BLM, BRAF, CAMK2B, CDK1, CSNK2A1, DAPK1, DYRK1A, EGFR, EPHB4, ERBB2, FLT3, FLT4, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP3K8, MAPK1, MAPK14, MET, MYLK, NEK2, NEK6, NUAK1, PDGFRB, PIK3CG, PIM1, PKM, PKN1, PLK1, PLK4, PTK2, PYGL, RECQL, SRC, SYK, TEK, TOP2A, TP53
BP GO:0051179; localization GO:0015701; bicarbonate transport 9.287E-18 3.875E-15 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, HBB
BP GO:0008152; metabolic process GO:0006730; one-carbon metabolic process 2.172E-15 4.778E-13 CA1, CA12, CA13, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9
Enriched KEGG Pathways of Target Proteins (Activity≤10μM)
Top 10, ordered by adjusted p-value

Detailed Information of Enriched KEGG Pathways
Pathway ID Pathway Name p-Value Adjusted p-Value Enriched Genes
hsa00910 Nitrogen metabolism_Homo sapiens_hsa00910 1.212E-22 2.437E-20 CA12; CA1; CA3; CA5B; CA2; CA5A; CA4; CA7; CA6; CA9; CA14; CA13
hsa05200 Pathways in cancer_Homo sapiens_hsa05200 2.769E-15 1.855E-13 PDGFRB; GSK3B; SMAD3; FLT3; DAPK1; MMP2; BRAF; PIK3R1; HIF1A; MMP9; EGFR; NFKB1; PIK3CG; PTK2; IGF1R; AR; ERBB2; BCL2; AKT1; MAPK1; PPARG; MET; TP53; PPARD
hsa05205 Proteoglycans in cancer_Homo sapiens_hsa05205 9.822E-16 9.871E-14 CAMK2B; SRC; MMP2; BRAF; PIK3R1; MAPK14; HIF1A; MMP9; PTK2; EGFR; PIK3CG; IGF1R; ERBB2; KDR; AKT1; MAPK1; TP53; MET; TLR2
hsa05215 Prostate cancer_Homo sapiens_hsa05215 4.530E-15 2.276E-13 PDGFRB; GSK3B; BRAF; PIK3R1; EGFR; NFKB1; PIK3CG; IGF1R; AR; ERBB2; BCL2; AKT1; MAPK1; TP53
hsa05230 Central carbon metabolism in cancer_Homo sapiens_hsa05230 8.535E-14 3.431E-12 PDGFRB; PKM; FLT3; ERBB2; AKT1; MAPK1; PIK3R1; TP53; MET; HIF1A; EGFR; PIK3CG
hsa04510 Focal adhesion_Homo sapiens_hsa04510 2.001E-13 6.704E-12 PDGFRB; GSK3B; SRC; FLT4; BRAF; PIK3R1; PTK2; EGFR; PIK3CG; MYLK; IGF1R; ERBB2; KDR; BCL2; AKT1; MAPK1; MET
hsa04151 PI3K-Akt signaling pathway_Homo sapiens_hsa04151 1.205E-12 3.027E-11 PDGFRB; GSK3B; SYK; INSR; FLT4; PIK3R1; PTK2; EGFR; NFKB1; PIK3CG; IGF1R; KDR; BCL2; AKT1; MAPK1; TEK; PKN1; TP53; MET; TLR2
hsa04066 HIF-1 signaling pathway_Homo sapiens_hsa04066 8.413E-13 2.416E-11 CAMK2B; INSR; PIK3R1; HIF1A; EGFR; NFKB1; PIK3CG; IGF1R; ERBB2; BCL2; AKT1; MAPK1; TEK
hsa05214 Glioma_Homo sapiens_hsa05214 5.234E-11 9.564E-10 PDGFRB; CAMK2B; AKT1; MAPK1; BRAF; PIK3R1; TP53; EGFR; PIK3CG; IGF1R
hsa04015 Rap1 signaling pathway_Homo sapiens_hsa04015 6.288E-11 9.722E-10 PDGFRB; SRC; INSR; FLT4; BRAF; PIK3R1; MAPK14; EGFR; PIK3CG; IGF1R; KDR; AKT1; MAPK1; TEK; MET
hsa04012 ErbB signaling pathway_Homo sapiens_hsa04012 5.011E-11 9.564E-10 CAMK2B; GSK3B; SRC; ERBB2; AKT1; MAPK1; BRAF; PIK3R1; EGFR; PTK2; PIK3CG
hsa05212 Pancreatic cancer_Homo sapiens_hsa05212 6.129E-11 9.722E-10 SMAD3; ERBB2; AKT1; MAPK1; BRAF; PIK3R1; TP53; EGFR; NFKB1; PIK3CG
hsa05219 Bladder cancer_Homo sapiens_hsa05219 1.683E-11 3.759E-10 DAPK1; SRC; MMP2; ERBB2; MAPK1; BRAF; MMP9; TP53; EGFR
hsa05218 Melanoma_Homo sapiens_hsa05218 1.299E-10 1.865E-09 PDGFRB; AKT1; MAPK1; BRAF; PIK3R1; TP53; MET; EGFR; PIK3CG; IGF1R
hsa05223 Non-small cell lung cancer_Homo sapiens_hsa05223 3.308E-10 3.997E-09 ALK; ERBB2; AKT1; MAPK1; BRAF; PIK3R1; TP53; EGFR; PIK3CG
hsa05213 Endometrial cancer_Homo sapiens_hsa05213 1.648E-10 2.208E-09 GSK3B; ERBB2; AKT1; MAPK1; BRAF; PIK3R1; TP53; EGFR; PIK3CG
hsa05160 Hepatitis C_Homo sapiens_hsa05160 3.579E-10 3.997E-09 GSK3B; AKT1; NR1H3; MAPK1; BRAF; PIK3R1; MAPK14; PPARA; TP53; EGFR; NFKB1; PIK3CG
hsa04068 FoxO signaling pathway_Homo sapiens_hsa04068 3.579E-10 3.997E-09 PLK4; SMAD3; INSR; PLK1; AKT1; MAPK1; BRAF; PIK3R1; MAPK14; EGFR; PIK3CG; IGF1R
hsa05161 Hepatitis B_Homo sapiens_hsa05161 1.057E-09 9.655E-09 SMAD3; SRC; BCL2; AKT1; MAPK1; STAT6; PIK3R1; TP53; MMP9; NFKB1; PIK3CG; TLR2
hsa04726 Serotonergic synapse_Homo sapiens_hsa04726 8.003E-10 8.043E-09 CYP2C9; APP; CYP2C8; MAOA; ALOX5; ALOX15; MAPK1; BRAF; ALOX12; CYP2C19; PTGS1
hsa05221 Acute myeloid leukemia_Homo sapiens_hsa05221 3.904E-10 4.130E-09 FLT3; PIM1; AKT1; MAPK1; BRAF; PIK3R1; NFKB1; PIK3CG; PPARD
hsa04014 Ras signaling pathway_Homo sapiens_hsa04014 1.807E-09 1.453E-08 PDGFRB; PLA2G1B; INSR; FLT4; PIK3R1; EGFR; NFKB1; PIK3CG; IGF1R; KDR; AKT1; MAPK1; TEK; MET
hsa04722 Neurotrophin signaling pathway_Homo sapiens_hsa04722 1.682E-09 1.409E-08 CAMK2B; GSK3B; BCL2; AKT1; MAPK1; BRAF; PIK3R1; MAPK14; TP53; NFKB1; PIK3CG
hsa05210 Colorectal cancer_Homo sapiens_hsa05210 8.527E-10 8.161E-09 GSK3B; SMAD3; BCL2; AKT1; MAPK1; BRAF; PIK3R1; TP53; PIK3CG
hsa04933 AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 4.464E-09 3.205E-08 SMAD3; MMP2; PIM1; BCL2; AKT1; MAPK1; PIK3R1; MAPK14; NFKB1; PIK3CG
hsa04668 TNF signaling pathway_Homo sapiens_hsa04668 1.029E-08 7.131E-08 MMP14; MMP3; AKT1; MAPK1; MAP3K8; PIK3R1; MAPK14; MMP9; NFKB1; PIK3CG
hsa01100 Metabolic pathways_Homo sapiens_hsa01100 3.731E-08 2.273E-07 DNMT1; PLA2G1B; MAOA; ALOX15; AKR1B1; ALOX12; PYGL; CYP2C19; CYP3A4; CYP19A1; HSD17B10; PTGS1; FUT7; HSD17B1; ALOX5; HSD17B2; XDH; AMY1A; GAA; AMY1B; AMY1C; PGD; TYR; CYP2C9; CYP2C8; PKM; CYP1A2; ALDH1A1; CYP1A1
hsa05169 Epstein-Barr virus infection_Homo sapiens_hsa05169 4.143E-08 2.449E-07 GSK3B; SYK; CSNK2A1; BCL2; CDK1; AKT1; PIK3R1; MAPK14; TP53; NFKB1; PIK3CG; HSPA1A
hsa04520 Adherens junction_Homo sapiens_hsa04520 4.304E-09 3.204E-08 SMAD3; CSNK2A1; SRC; INSR; ERBB2; MAPK1; MET; EGFR; IGF1R
hsa05145 Toxoplasmosis_Homo sapiens_hsa05145 2.032E-08 1.276E-07 ALOX5; BCL2; AKT1; MAPK1; PIK3R1; MAPK14; NFKB1; PIK3CG; HSPA1A; TLR2
hsa05206 MicroRNAs in cancer_Homo sapiens_hsa05206 5.486E-08 2.980E-07 PDGFRB; DNMT1; ABCC1; ABCB1; MMP9; EGFR; NFKB1; ERBB2; PIM1; BCL2; CYP1B1; MAPK1; TP53; MET
hsa04913 Ovarian steroidogenesis_Homo sapiens_hsa04913 3.413E-09 2.638E-08 HSD17B1; ALOX5; INSR; HSD17B2; CYP1A1; CYP1B1; CYP19A1; IGF1R
hsa04370 VEGF signaling pathway_Homo sapiens_hsa04370 1.746E-08 1.170E-07 SRC; KDR; AKT1; MAPK1; PIK3R1; MAPK14; PTK2; PIK3CG
hsa04914 Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 5.261E-08 2.937E-07 PLK1; CDK1; AKT1; MAPK1; BRAF; PIK3R1; MAPK14; PIK3CG; IGF1R
hsa04915 Estrogen signaling pathway_Homo sapiens_hsa04915 5.751E-08 3.042E-07 SRC; MMP2; AKT1; MAPK1; PIK3R1; MMP9; EGFR; PIK3CG; HSPA1A
hsa00590 Arachidonic acid metabolism_Homo sapiens_hsa00590 1.992E-08 1.276E-07 CYP2C9; CYP2C8; PLA2G1B; ALOX5; ALOX15; ALOX12; CYP2C19; PTGS1
hsa05202 Transcriptional misregulation in cancer_Homo sapiens_hsa05202 1.164E-07 5.707E-07 HPGD; FLT3; MMP3; PPARG; TP53; MPO; MMP9; MET; NFKB1; PTK2; IGF1R
hsa04931 Insulin resistance_Homo sapiens_hsa04931 1.329E-07 6.361E-07 GSK3B; INSR; AKT1; NR1H3; PIK3R1; PYGL; PPARA; NFKB1; PIK3CG
hsa04010 MAPK signaling pathway_Homo sapiens_hsa04010 5.186E-07 2.218E-06 PDGFRB; DUSP3; AKT1; MAPK1; BRAF; MAP3K8; MAPT; MAPK14; TP53; EGFR; NFKB1; HSPA1A
hsa04917 Prolactin signaling pathway_Homo sapiens_hsa04917 6.620E-08 3.412E-07 GSK3B; SRC; AKT1; MAPK1; PIK3R1; MAPK14; NFKB1; PIK3CG
hsa05220 Chronic myeloid leukemia_Homo sapiens_hsa05220 7.388E-08 3.712E-07 SMAD3; AKT1; MAPK1; BRAF; PIK3R1; TP53; NFKB1; PIK3CG
hsa04611 Platelet activation_Homo sapiens_hsa04611 3.501E-07 1.530E-06 SYK; SRC; AKT1; MAPK1; PIK3R1; MAPK14; PIK3CG; MYLK; PTGS1
hsa04071 Sphingolipid signaling pathway_Homo sapiens_hsa04071 3.040E-07 1.358E-06 ABCC1; BCL2; AKT1; MAPK1; PIK3R1; MAPK14; TP53; NFKB1; PIK3CG
hsa03320 PPAR signaling pathway_Homo sapiens_hsa03320 4.713E-08 2.707E-07 FABP2; FABP3; FABP4; FABP5; NR1H3; PPARG; PPARA; PPARD
hsa05162 Measles_Homo sapiens_hsa05162 8.790E-07 3.534E-06 GSK3B; CSNK2A1; AKT1; PIK3R1; TP53; NFKB1; PIK3CG; HSPA1A; TLR2
hsa04211 Longevity regulating pathway - mammal_Homo sapiens_hsa04211 5.358E-07 2.244E-06 INSR; AKT1; PPARG; PIK3R1; TP53; NFKB1; PIK3CG; IGF1R
hsa04072 Phospholipase D signaling pathway_Homo sapiens_hsa04072 1.419E-06 5.093E-06 PDGFRB; SYK; CXCR1; INSR; AKT1; MAPK1; PIK3R1; EGFR; PIK3CG
hsa04062 Chemokine signaling pathway_Homo sapiens_hsa04062 1.515E-06 5.341E-06 GSK3B; CXCR1; SRC; AKT1; MAPK1; BRAF; PIK3R1; NFKB1; PTK2; PIK3CG
hsa05142 Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 1.164E-06 4.414E-06 SMAD3; AKT1; MAPK1; PIK3R1; MAPK14; NFKB1; PIK3CG; TLR2
hsa05203 Viral carcinogenesis_Homo sapiens_hsa05203 3.460E-06 1.159E-05 POLB; PKM; SYK; SRC; CDK1; MAPK1; PIK3R1; TP53; NFKB1; PIK3CG
hsa04660 T cell receptor signaling pathway_Homo sapiens_hsa04660 1.164E-06 4.414E-06 GSK3B; AKT1; MAPK1; MAP3K8; PIK3R1; MAPK14; NFKB1; PIK3CG
hsa04620 Toll-like receptor signaling pathway_Homo sapiens_hsa04620 1.346E-06 4.918E-06 AKT1; MAPK1; MAP3K8; PIK3R1; MAPK14; NFKB1; PIK3CG; TLR2
hsa00591 Linoleic acid metabolism_Homo sapiens_hsa00591 1.576E-09 1.377E-08 CYP2C9; CYP2C8; PLA2G1B; CYP1A2; ALOX15; CYP3A4; CYP2C19
hsa04810 Regulation of actin cytoskeleton_Homo sapiens_hsa04810 5.069E-06 1.643E-05 PDGFRB; SRC; MAPK1; BRAF; PIK3R1; F2; PTK2; EGFR; PIK3CG; MYLK
hsa04923 Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 1.977E-07 9.243E-07 FABP4; INSR; AKT1; PIK3R1; TSHR; PIK3CG; PTGS1
hsa04919 Thyroid hormone signaling pathway_Homo sapiens_hsa04919 3.026E-06 1.031E-05 GSK3B; SRC; AKT1; MAPK1; PIK3R1; TP53; HIF1A; PIK3CG
hsa04662 B cell receptor signaling pathway_Homo sapiens_hsa04662 1.249E-06 4.649E-06 GSK3B; SYK; AKT1; MAPK1; PIK3R1; NFKB1; PIK3CG
hsa05211 Renal cell carcinoma_Homo sapiens_hsa05211 6.238E-07 2.559E-06 AKT1; MAPK1; BRAF; PIK3R1; MET; HIF1A; PIK3CG
hsa05152 Tuberculosis_Homo sapiens_hsa05152 8.098E-06 2.466E-05 CAMK2B; SYK; SRC; BCL2; AKT1; MAPK1; MAPK14; NFKB1; TLR2
hsa04380 Osteoclast differentiation_Homo sapiens_hsa04380 6.975E-06 2.157E-05 SYK; AKT1; MAPK1; PPARG; PIK3R1; MAPK14; NFKB1; PIK3CG
hsa04210 Apoptosis_Homo sapiens_hsa04210 1.075E-05 3.088E-05 LMNA; BCL2; AKT1; MAPK1; PIK3R1; TP53; NFKB1; PIK3CG
hsa04912 GnRH signaling pathway_Homo sapiens_hsa04912 5.545E-06 1.769E-05 CAMK2B; MMP14; SRC; MMP2; MAPK1; MAPK14; EGFR
hsa04910 Insulin signaling pathway_Homo sapiens_hsa04910 1.020E-05 2.972E-05 GSK3B; INSR; AKT1; MAPK1; BRAF; PIK3R1; PYGL; PIK3CG
hsa04550 Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 1.193E-05 3.263E-05 GSK3B; SMAD3; AKT1; MAPK1; PIK3R1; MAPK14; PIK3CG; IGF1R
hsa00140 Steroid hormone biosynthesis_Homo sapiens_hsa00140 2.532E-07 1.157E-06 HSD17B1; CYP1A2; HSD17B2; CYP1A1; CYP1B1; CYP3A4; CYP19A1
hsa05222 Small cell lung cancer_Homo sapiens_hsa05222 3.798E-06 1.251E-05 BCL2; AKT1; PIK3R1; TP53; NFKB1; PTK2; PIK3CG
hsa04932 Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 1.865E-05 4.870E-05 GSK3B; INSR; AKT1; NR1H3; PIK3R1; PPARA; NFKB1; PIK3CG
hsa05204 Chemical carcinogenesis_Homo sapiens_hsa05204 2.755E-06 9.548E-06 CYP2C9; CYP2C8; CYP1A2; CYP1A1; CYP1B1; CYP3A4; CYP2C19
hsa05166 HTLV-I infection_Homo sapiens_hsa05166 2.578E-05 6.478E-05 PDGFRB; POLB; GSK3B; SMAD3; TERT; AKT1; PIK3R1; TP53; NFKB1; PIK3CG
hsa05231 Choline metabolism in cancer_Homo sapiens_hsa05231 1.107E-05 3.134E-05 PDGFRB; AKT1; MAPK1; PIK3R1; HIF1A; EGFR; PIK3CG
hsa04024 cAMP signaling pathway_Homo sapiens_hsa04024 1.977E-05 5.095E-05 CAMK2B; AKT1; MAPK1; BRAF; PIK3R1; PPARA; NFKB1; TSHR; PIK3CG
hsa04022 cGMP-PKG signaling pathway_Homo sapiens_hsa04022 3.845E-05 9.426E-05 INSR; AKT1; MAPK1; PIK3R1; ADRA2C; ADRA2A; PIK3CG; MYLK
hsa05164 Influenza A_Homo sapiens_hsa05164 5.359E-05 1.282E-04 GSK3B; AKT1; MAPK1; PIK3R1; MAPK14; NFKB1; PIK3CG; HSPA1A
hsa04725 Cholinergic synapse_Homo sapiens_hsa04725 2.054E-05 5.225E-05 CAMK2B; ACHE; BCL2; AKT1; MAPK1; PIK3R1; PIK3CG
hsa04630 Jak-STAT signaling pathway_Homo sapiens_hsa04630 1.923E-04 4.295E-04 THPO; PIM1; BCL2; AKT1; STAT6; PIK3R1; PIK3CG
hsa04261 Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 1.283E-04 2.931E-04 CAMK2B; BCL2; AKT1; MAPK1; PIK3R1; MAPK14; PIK3CG
hsa04114 Oocyte meiosis_Homo sapiens_hsa04114 3.985E-05 9.650E-05 CAMK2B; AR; PLK1; CDK1; MAPK1; AURKA; IGF1R
hsa04921 Oxytocin signaling pathway_Homo sapiens_hsa04921 1.923E-04 4.295E-04 CAMK2B; SRC; MAPK1; PIK3R1; EGFR; PIK3CG; MYLK
hsa04144 Endocytosis_Homo sapiens_hsa04144 7.681E-04 1.514E-03 SMAD3; CXCR1; SRC; KDR; MET; EGFR; HSPA1A; IGF1R
hsa04060 Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 8.908E-04 1.738E-03 PDGFRB; CXCR1; THPO; FLT3; FLT4; KDR; MET; EGFR
hsa04080 Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 4.972E-03 8.690E-03 GPR35; NMUR2; F2; ADRA2C; ADRA2A; DRD4; TSHR
hsa04750 Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 9.607E-05 2.220E-04 CAMK2B; SRC; ALOX12; PIK3R1; MAPK14; PIK3CG
hsa04310 Wnt signaling pathway_Homo sapiens_hsa04310 7.132E-04 1.419E-03 CAMK2B; GSK3B; SMAD3; CSNK2A1; TP53; PPARD
hsa04020 Calcium signaling pathway_Homo sapiens_hsa04020 1.160E-02 1.895E-02 PDGFRB; CAMK2B; ERBB2; EGFR; MYLK
hsa04152 AMPK signaling pathway_Homo sapiens_hsa04152 3.475E-04 7.276E-04 INSR; AKT1; PPARG; PIK3R1; PIK3CG; IGF1R
hsa04150 mTOR signaling pathway_Homo sapiens_hsa04150 5.773E-06 1.813E-05 AKT1; MAPK1; BRAF; PIK3R1; HIF1A; PIK3CG
hsa04728 Dopaminergic synapse_Homo sapiens_hsa04728 4.293E-04 8.896E-04 CAMK2B; GSK3B; MAOA; AKT1; MAPK14; DRD4
hsa05168 Herpes simplex infection_Homo sapiens_hsa05168 1.293E-02 2.063E-02 CSNK2A1; CDK1; TP53; NFKB1; TLR2
hsa05010 Alzheimer's disease_Homo sapiens_hsa05010 1.697E-03 3.159E-03 BACE1; APP; GSK3B; MAPK1; MAPT; HSD17B10
hsa04670 Leukocyte transendothelial migration_Homo sapiens_hsa04670 2.660E-04 5.689E-04 MMP2; PIK3R1; MAPK14; MMP9; PTK2; PIK3CG
hsa04650 Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 3.525E-03 6.326E-03 SYK; MAPK1; BRAF; PIK3R1; PIK3CG
hsa04213 Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 8.434E-06 2.530E-05 INSR; AKT1; PIK3R1; PIK3CG; HSPA1A; IGF1R
hsa04664 Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 1.201E-05 3.263E-05 SYK; AKT1; MAPK1; PIK3R1; MAPK14; PIK3CG
hsa04110 Cell cycle_Homo sapiens_hsa04110 2.444E-03 4.466E-03 GSK3B; SMAD3; PLK1; CDK1; TP53
hsa04360 Axon guidance_Homo sapiens_hsa04360 2.711E-03 4.909E-03 GSK3B; MAPK1; MET; PTK2; EPHB4
hsa04270 Vascular smooth muscle contraction_Homo sapiens_hsa04270 1.276E-02 2.053E-02 PLA2G1B; MAPK1; BRAF; MYLK
hsa04922 Glucagon signaling pathway_Homo sapiens_hsa04922 9.863E-04 1.888E-03 CAMK2B; PKM; AKT1; PYGL; PPARA
hsa04666 Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 6.789E-04 1.365E-03 SYK; AKT1; MAPK1; PIK3R1; PIK3CG
hsa04916 Melanogenesis_Homo sapiens_hsa04916 6.832E-03 1.154E-02 CAMK2B; GSK3B; MAPK1; TYR
hsa05146 Amoebiasis_Homo sapiens_hsa05146 9.431E-04 1.823E-03 PIK3R1; NFKB1; PTK2; PIK3CG; TLR2
hsa00830 Retinol metabolism_Homo sapiens_hsa00830 9.235E-06 2.730E-05 CYP2C9; CYP2C8; CYP1A2; ALDH1A1; CYP1A1; CYP3A4
hsa05323 Rheumatoid arthritis_Homo sapiens_hsa05323 3.025E-02 4.438E-02 MMP3; TEK; TLR2
hsa04970 Salivary secretion_Homo sapiens_hsa04970 2.940E-02 4.345E-02 AMY1A; AMY1B; AMY1C
hsa04973 Carbohydrate digestion and absorption_Homo sapiens_hsa04973 1.030E-06 4.060E-06 AMY1A; AMY1B; AMY1C; AKT1; PIK3R1; PIK3CG
hsa04064 NF-kappa B signaling pathway_Homo sapiens_hsa04064 5.296E-03 9.176E-03 SYK; CSNK2A1; BCL2; NFKB1
hsa05120 Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 1.201E-05 3.263E-05 CXCR1; SRC; MAPK14; MET; EGFR; NFKB1
hsa04540 Gap junction_Homo sapiens_hsa04540 5.273E-04 1.081E-03 PDGFRB; SRC; CDK1; MAPK1; EGFR
hsa04976 Bile secretion_Homo sapiens_hsa04976 1.543E-05 4.081E-05 SLCO1B1; ABCB1; CA2; SLCO1B3; CYP3A4; ABCG2
hsa00982 Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 1.308E-05 3.505E-05 CYP2C9; CYP2C8; MAOA; CYP1A2; CYP3A4; CYP2C19
hsa05132 Salmonella infection_Homo sapiens_hsa05132 4.010E-03 7.132E-03 MAPK1; PKN1; MAPK14; NFKB1
hsa05100 Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 3.017E-04 6.383E-04 SRC; PIK3R1; MET; PTK2; PIK3CG
hsa04971 Gastric acid secretion_Homo sapiens_hsa04971 1.819E-02 2.812E-02 CAMK2B; CA2; MYLK
hsa05133 Pertussis_Homo sapiens_hsa05133 1.885E-02 2.892E-02 MAPK1; MAPK14; NFKB1
hsa04920 Adipocytokine signaling pathway_Homo sapiens_hsa04920 1.570E-02 2.465E-02 AKT1; PPARA; NFKB1
hsa00980 Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 2.212E-04 4.833E-04 CYP2C9; CYP1A2; CYP1A1; CYP1B1; CYP3A4
hsa05140 Leishmaniasis_Homo sapiens_hsa05140 2.215E-03 4.085E-03 MAPK1; MAPK14; NFKB1; TLR2
hsa04720 Long-term potentiation_Homo sapiens_hsa04720 1.341E-02 2.122E-02 CAMK2B; MAPK1; BRAF
hsa04730 Long-term depression_Homo sapiens_hsa04730 1.036E-02 1.706E-02 MAPK1; BRAF; IGF1R
hsa05131 Shigellosis_Homo sapiens_hsa05131 1.443E-03 2.711E-03 SRC; MAPK1; MAPK14; NFKB1
hsa04621 NOD-like receptor signaling pathway_Homo sapiens_hsa04621 9.001E-03 1.495E-02 MAPK1; MAPK14; NFKB1
hsa05321 Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 1.443E-03 2.711E-03 SMAD3; STAT6; NFKB1; TLR2
hsa05134 Legionellosis_Homo sapiens_hsa05134 8.159E-03 1.367E-02 NFKB1; TLR2; HSPA1A
hsa00500 Starch and sucrose metabolism_Homo sapiens_hsa00500 6.230E-05 1.458E-04 AMY1A; AMY1B; GAA; AMY1C; PYGL
hsa05014 Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 6.619E-03 1.127E-02 BCL2; MAPK14; TP53
hsa05144 Malaria_Homo sapiens_hsa05144 5.920E-03 1.017E-02 HBB; MET; TLR2
hsa04930 Type II diabetes mellitus_Homo sapiens_hsa04930 2.931E-05 7.273E-05 PKM; INSR; MAPK1; PIK3R1; PIK3CG
hsa05020 Prion diseases_Homo sapiens_hsa05020 2.828E-02 4.211E-02 MAPK1; HSPA1A
hsa02010 ABC transporters_Homo sapiens_hsa02010 4.373E-03 7.710E-03 ABCC1; ABCB1; ABCG2
hsa00052 Galactose metabolism_Homo sapiens_hsa00052 2.119E-02 3.226E-02 GAA; AKR1B1
hsa00350 Tyrosine metabolism_Homo sapiens_hsa00350 2.828E-02 4.211E-02 MAOA; TYR
hsa04960 Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 2.038E-04 4.502E-04 INSR; MAPK1; PIK3R1; PIK3CG
hsa03410 Base excision repair_Homo sapiens_hsa03410 2.534E-02 3.830E-02 POLB; APEX1
hsa04320 Dorso-ventral axis formation_Homo sapiens_hsa04320 1.735E-02 2.703E-02 MAPK1; EGFR
hsa00380 Tryptophan metabolism_Homo sapiens_hsa00380 2.252E-04 4.867E-04 MAOA; CYP1A2; CYP1A1; CYP1B1
hsa05216 Thyroid cancer_Homo sapiens_hsa05216 6.239E-05 1.458E-04 MAPK1; BRAF; PPARG; TP53
hsa04964 Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 1.275E-02 2.053E-02 CA2; CA4
hsa00232 Caffeine metabolism_Homo sapiens_hsa00232 5.506E-04 1.118E-03 CYP1A2; XDH
Human Diseases Associated with the Target Proteins of the Plant (Activity≤10μM)

Detailed Information of Human Diseases
ICD10 Disease Category Disease Name ICD10 Code Linked Targets
I00-I99: Diseases of the circulatory system Cerebral amyloid angiopathy I68.0 APP
G00-G99: Diseases of the nervous system G00-G99 Central nervous system disease G00-G99 MAPT; PPARD
C00-D49: Neoplasms Refractory breast cancer C50 EGFR
S00-T88: Injury, poisoning and certain other consequences of external causes Radiation sickness T66 TLR2
C00-D49: Neoplasms Refractory renal cell carcinoma C64 PKM
I00-I99: Diseases of the circulatory system Atherosclerosis I70 NR1I2; ALOX5; PPARD
J00-J99: Diseases of the respiratory system Asthma J45 PLA2G1B; ESRRA; SYK; SYK; ALOX5; ALOX5; ERBB2; ADRA2C
C00-D49: Neoplasms Urethral cancer NA EGFR
NA: NA Upper abdominal bloating NA ACHE
K00-K95: Diseases of the digestive system Ulcerative colitis K51 PTGS1; MMP9
N00-N99: Diseases of the genitourinary system Urinary dysfunction N39.3-N39.4 ACHE
NA: NA Early satiation associated with functional dyspepsia NA ACHE
C00-D49: Neoplasms Clear cell renal cell carcinoma C64 CA9
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Cognitive disorders F01-F07, F04, F05, R41.3 MAPT; ACHE
C00-D49: Neoplasms Advanced melanoma C43 BCL2
E00-E89: Endocrine, nutritional and metabolic diseases Hyperuricaemia in gout E79.0, M10 XDH
C00-D49: Neoplasms Mesothelioma C45 PTK2
C00-D49: Neoplasms Female androgenresponsive recurrent mammary cancer C50 AR
C00-D49: Neoplasms Myeloid leukemia C92 FLT3
I00-I99: Diseases of the circulatory system Renal artery disease I70.1 TP53
C00-D49: Neoplasms Renal cancer C64 F10; CA9; KDR
C00-D49: Neoplasms Renal cell carcinoma NA MMP2; KDR; KDR
E00-E89: Endocrine, nutritional and metabolic diseases Atrial fibrillation E78, I48 F10; F2
L00-L99: Diseases of the skin and subcutaneous tissue Atopic dermatitis L00-L99 F2; ALOX5
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Attention deficit hyperactivity disorder F90 F10; ADRA2A
E00-E89: Endocrine, nutritional and metabolic diseases Autoimmune diabetes E08-E13 SYK; INSR; TLR2
E00-E89: Endocrine, nutritional and metabolic diseases Hyperuricemia E79.0 XDH
E00-E89: Endocrine, nutritional and metabolic diseases Hypoglycemia E16.0-E16.2 INSR
C00-D49: Neoplasms HER2-positive urogenital cancer NA ERBB2
C00-D49: Neoplasms Tumors C00-D48 TERT
E00-E89: Endocrine, nutritional and metabolic diseases Type 1 diabetes E10 INSR; PPARG; PPARD
C00-D49: Neoplasms Thyroid cancer diagnosis C73 TSHR
S00-T88: Injury, poisoning and certain other consequences of external causes Toxicity T36-T50, T51-T65 TP53
E00-E89: Endocrine, nutritional and metabolic diseases Type 1/2 diabetes E08-E13 INSR
E00-E89: Endocrine, nutritional and metabolic diseases Type 2 diabetes E11 FFAR1; PIK3CG; PIK3CG; INSR; NFKB1; PPARG; PPARG; PPARD
C00-D49: Neoplasms Chronic lymphocytic leukaemia C91 SYK; EGFR; BCL2
C00-D49: Neoplasms Chronic myelogenous leukaemia C92.1 SRC
J00-J99: Diseases of the respiratory system Chronic obstructive pulmonary disease J40-J44, J47 MPO; ALOX5; MAPK14
A00-B99: Certain infectious and parasitic diseases Human immunodeficiency virus infection B20-B26 FLT3
M00-M99: Diseases of the musculoskeletal system and connective tissue Arthritis M00-M25 PLA2G1B; ABCC1; ESRRA; PIK3CG; TEK; ALOX5; MAPK14
I00-I99: Diseases of the circulatory system Arteriosclerosis I70 PLA2G1B
A00-B99: Certain infectious and parasitic diseases Infections disease A00-B99 MPO
C00-D49: Neoplasms CLL NA FLT3
E00-E89: Endocrine, nutritional and metabolic diseases Diabetes E23.2, N25.1 FFAR1; AKR1B1; GSK3B; PDGFRB; INSR; PPARG
I00-I99: Diseases of the circulatory system Deep venous clots I80.2 F10
L00-L99: Diseases of the skin and subcutaneous tissue Psoriasis L40 FLT3; ALOX5; MAPK14; EGFR; BCL2
I00-I99: Diseases of the circulatory system Prophylaxis of deep vein thrombosis I80-I82, I80.2 F10
NA: NA Anaplastic mixed oligoastrocytoma NA FLT3
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified Anesthesia R20.0 FAAH
E00-E89: Endocrine, nutritional and metabolic diseases Amyloidosis E85 APP
G00-G99: Diseases of the nervous system G00-G99 Amyotrophic lateral sclerosis G12.2 BCL2
S00-T88: Injury, poisoning and certain other consequences of external causes Poisoning due to pesticides and chemicals T36-T50 ACHE
A00-B99: Certain infectious and parasitic diseases Visceral leishmaniasis B55.0 PLA2G1B
L00-L99: Diseases of the skin and subcutaneous tissue Vitiligo L80 MAOA; TYR
H00-H59: Diseases of the eye and adnexa Macular degeneration H35.3 APP
NA: NA Christmas disease NA F10
H00-H59: Diseases of the eye and adnexa Choroidal neovascularisation H35 ESRRA
K00-K95: Diseases of the digestive system Chemotherapy-induced mucositis K12.3 MET
G00-G99: Diseases of the nervous system G00-G99 Multiple scierosis G35 MPO; F2
K00-K95: Diseases of the digestive system Duodenal ulcers K25-K27 CA1; MYLK; CA2
I00-I99: Diseases of the circulatory system Pulmonary arterial hypertension I27.0, I27.2 HIF1A
K00-K95: Diseases of the digestive system Non-alcoholic fatty liver disease K76.0 PPARG; PPARD
I00-I99: Diseases of the circulatory system Angiogenesis disorder I00-I99 KDR
NA: NA Angioedema NA PIK3CG
I00-I99: Diseases of the circulatory system Angina pectoris I20 F10; F2
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Anxiety disorder F32, F40-F42 CAMK2B; MAOA; ACHE; FAAH; CYP3A4
S00-T88: Injury, poisoning and certain other consequences of external causes Vascular restinosis following vascular graft surgery T82.858A FLT4
I00-I99: Diseases of the circulatory system Venous thromboembolism I80-I82 F10; F2
I00-I99: Diseases of the circulatory system Venous thrombosis I80-I82 F10; F2
H00-H59: Diseases of the eye and adnexa Ocular disease H00-H59 ADRA2C
I00-I99: Diseases of the circulatory system Cerebrovascular ischaemia I61-I63 F10; EGFR
I00-I99: Diseases of the circulatory system Coagulation I80-I82 F10; F2
C00-D49: Neoplasms Esophageal cancer C15 EGFR
L00-L99: Diseases of the skin and subcutaneous tissue Erythema L51-L54 ADRA2C
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Erectile dysfunction F52.2, N48.4 DRD4
G00-G99: Diseases of the nervous system G00-G99 Epileptic seizures G40, P90, R56 ACHE
G00-G99: Diseases of the nervous system G00-G99 Epilepsy G40 MAOA
NA: NA Enthesopathy NA PIK3CG
C00-D49: Neoplasms Thyroid cancer C73 BRAF; TSHR; KDR
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Sexual dysfunction F52 ADRA2A
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Alcohol use disorders F10.2 MAOA; ADRA2C
K00-K95: Diseases of the digestive system Alcoholic hepatitis K70.1 AR
J00-J99: Diseases of the respiratory system Airway inflammation J00-J99 FLT3
C00-D49: Neoplasms Castration-resistant prostate cancer C61 AR
I00-I99: Diseases of the circulatory system Cardiovascular disorder I00-I99 AR; PIK3CG; F2; KDR
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure Diagnostic test to differentiate primary and secondary hypothyroidism W88 TSHR
NA: NA Nonvalvular atrial fibrillation NA F2
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Nicotine dependence F17 PPARG
G00-G99: Diseases of the nervous system G00-G99 Mild to moderate alzheimer disease G30 APP
C00-D49: Neoplasms Solid tumours C00-D48 AKT1; MET; PKM; ABCB1; SYK; PIK3CG; FLT3; CA9; F2; MMP2; MMP14; SRC; IGF1R; PTK2; AURKB; AURKA; FLT4; TEK; PDGFRB; HIF1A; MAPK1; MMP9; ERBB2; EGFR; TLR2; TP53; KDR; KDR; KDR; PLK1; PLK1; TOP2A
C00-D49: Neoplasms Soft tissue sarcoma C00-D49 DNMT1
C00-D49: Neoplasms Solid tumors NA BRAF
S00-T88: Injury, poisoning and certain other consequences of external causes Allergy T78.4 PLA2G1B; SYK; ALOX5
G00-G99: Diseases of the nervous system G00-G99 Alzheimer disease G30 MAOA; GSK3B; MAPT; ACHE; ACHE; ACHE; INSR; ADRA2C; PPARG; PPARG; APP
L00-L99: Diseases of the skin and subcutaneous tissue Alopecia L65.9 AR
J00-J99: Diseases of the respiratory system Allergic rhinitis J00, J30, J31.0, T78.4 PLA2G1B; ESRRA; ADRA2C
I00-I99: Diseases of the circulatory system Ischemic stroke I61-I63 MMP3
E00-E89: Endocrine, nutritional and metabolic diseases Hyperglycaemia in type 2 diabetes E11, R73.9 INSR
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified Cachexia R64 AR; ESRRA
A00-B99: Certain infectious and parasitic diseases Bacterial infections A00-B99 ABCB1; PIK3CG; CYP2C9
E00-E89: Endocrine, nutritional and metabolic diseases Diabetic neuropathy E11.40 AKR1B1; PTGS1
S00-T88: Injury, poisoning and certain other consequences of external causes Poison intoxication T36-T50 ACHE; ADRA2C
C00-D49: Neoplasms Peritoneal cavity cancer NA KDR
E00-E89: Endocrine, nutritional and metabolic diseases Dyslipidaemias E78 PPARD; PPARD
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Insomnia F51.0, G47.0 CA2
L00-L99: Diseases of the skin and subcutaneous tissue Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses L20-L30 PLA2G1B
H00-H59: Diseases of the eye and adnexa Retinal venous occlusion H34.8 ERBB2
J00-J99: Diseases of the respiratory system Rhinitis J00, J30, J31.0 ALOX5
C00-D49: Neoplasms Advanced breast cancer C50 CYP19A1; SRC
NA: NA Acute respiratory distress syndrome NA MAPK14
C00-D49: Neoplasms Brain cancer C71, D33 TERT; SRC; EGFR; EGFR
S00-T88: Injury, poisoning and certain other consequences of external causes Brain injury S09.90 PDGFRB; APP
C00-D49: Neoplasms Breast cancer C50 AR; TERT; CYP19A1; PIK3CG; FLT3; FLT3; CA9; IGF1R; INSR; CDK1; ERBB2; ERBB2; ERBB2; EGFR; EGFR; EGFR; BCL2; KDR; KDR; KDR
C00-D49: Neoplasms Glioma C71 PIK3CG; EGFR; EGFR; KDR; APP
A00-B99: Certain infectious and parasitic diseases Fungal infections B35-B49 ALOX5
G00-G99: Diseases of the nervous system G00-G99 Encephalopathy G93.4 XDH
E00-E89: Endocrine, nutritional and metabolic diseases Endocrine disease E00-E35 AR
I00-I99: Diseases of the circulatory system Edema associated with congestive heart failure I50, R60.9 CA2
C00-D49: Neoplasms Endometrial cancer C54.1 PIK3CG; PIK3CG
N00-N99: Diseases of the genitourinary system Endometriosis N80 CYP19A1; PPARG
G00-G99: Diseases of the nervous system G00-G99 Pain G64, G90.0, R52, G89 AR; PKM; MMP13; ACHE; PTGS1; IGF1R; INSR; CDK1; ADRA2C; ADRA2A; FAAH
C00-D49: Neoplasms Advanced prostate cancer C61 AR
C00-D49: Neoplasms Advanced malignancies C00-C96 KDR
C00-D49: Neoplasms Advanced cancers C00-C96 EGFR
C00-D49: Neoplasms Advanced renal cell carcinoma C64 KDR; KDR
C00-D49: Neoplasms Bladder cancer C67 AR; CYP19A1; ERBB2; EGFR
C00-D49: Neoplasms Biliary cancer C22, C24 KDR
I00-I99: Diseases of the circulatory system Bleeding I74, I80-I82 F10; F2
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism Blood coagulation disorders D65-D68 F10; F2
C00-D49: Neoplasms Hematologic malignancies C81-C86 AKT1; PIK3CG
J00-J99: Diseases of the respiratory system Respiratory disease J00-J99 ALOX5
I00-I99: Diseases of the circulatory system Restenosis I51.89 MAPK1
E00-E89: Endocrine, nutritional and metabolic diseases Obesity E66 ADRA2C; PPARG; PPARD; PPARD
C00-D49: Neoplasms Non-small-cell lung cancer NA KDR
E00-E89: Endocrine, nutritional and metabolic diseases Non-insulin dependent diabetes E11.9 FFAR1; ESRRA; INSR
C00-D49: Neoplasms Non-hodgkin's lymphoma C85 SYK; PIK3CG; PIK3CG; ERBB2; PLK1
I00-I99: Diseases of the circulatory system Hypotension I95 ADRA2C
E00-E89: Endocrine, nutritional and metabolic diseases Hypogonadism E23.0, E28.3, E29.1 AR
L00-L99: Diseases of the skin and subcutaneous tissue Diabetic foot ulcer L88-L89 EGFR
E00-E89: Endocrine, nutritional and metabolic diseases Diabetic complication E08-E13 AKR1B1
E00-E89: Endocrine, nutritional and metabolic diseases Diabetic cataract E10.36, E11.36 AKR1B1
H00-H59: Diseases of the eye and adnexa Diabetic retinopathy H36, E10.3, E11.3, E13.3 MAPK14
E00-E89: Endocrine, nutritional and metabolic diseases Diabetic nephropathy E11.21 ADRA2C
G00-G99: Diseases of the nervous system G00-G99 Diagnostic imaging G30, I73.9 APP
C00-D49: Neoplasms Gliosarcoma NA FLT3
C00-D49: Neoplasms Glioblastoma multiforme C71 DNMT1; SRC; ERBB2; EGFR; EGFR
C00-D49: Neoplasms Glioblastoma NA FLT3
H00-H59: Diseases of the eye and adnexa Glaucoma H40-H42 AKR1B1; CA1; CA1; ACHE; ADRA2C
NA: NA GIST NA FLT3
NA: NA Geographic retinal atrophy NA APP
M00-M99: Diseases of the musculoskeletal system and connective tissue Gout M10 AKR1B1; ABCC1; ABCC1; XDH; PPARG
C00-D49: Neoplasms Malignant adrenal gland cancer C74.0 IGF1R
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Mild cognitive impairment F06.7 ACHE; APP
C00-D49: Neoplasms Melanoma C43 TERT; BRAF; EGFR; TLR2; TYR; KDR; KDR
G00-G99: Diseases of the nervous system G00-G99 Neurodegenerative disease G30-G32 MAPT; ACHE
G00-G99: Diseases of the nervous system G00-G99 Neuropathic pain G64, G90.0 MAOA; PTGS1
I00-I99: Diseases of the circulatory system Stroke I61-I63, I80-I82 MMP9
C00-D49: Neoplasms Diffuse large B-cell lymphoma C83.3 PIK3CG
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Drug abuse F10-F19 PPARG
E00-E89: Endocrine, nutritional and metabolic diseases Dietary shortage E40-E46 PTGS1
C00-D49: Neoplasms Non-small cell lung cancer C33-C34 MET; ABCB1; DNMT1; IGF1R; IGF1R; PDGFRB; EGFR; EGFR; AXL; KDR
C00-D49: Neoplasms Hormonally-responsive breast cancer C50 CYP19A1
J00-J99: Diseases of the respiratory system Acute lung injury J80 MAPK14
C00-D49: Neoplasms Gastrointestinal cancers C15-C26 ERBB2; KDR
K00-K95: Diseases of the digestive system Gastrointestinal disease K00-K93 ESRRA; EGFR
L00-L99: Diseases of the skin and subcutaneous tissue Acne vulgaris L70.0 AR; AR; ESRRA; MMP2; PTGS1
I00-I99: Diseases of the circulatory system Myocardial infarction I21, I22 PIK3CG; F2; F2; MMP3
S00-T88: Injury, poisoning and certain other consequences of external causes Myocardial reperfusion injury T86.4 AKT1
S00-T88: Injury, poisoning and certain other consequences of external causes Nerve injury T14.4 PLA2G1B
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified Chronic pain R52.1-R52.2, G89 ERBB2
K00-K95: Diseases of the digestive system Crohn's disease K50 INSR
A00-B99: Certain infectious and parasitic diseases Cryptosporidium infection A07.2 EGFR
I00-I99: Diseases of the circulatory system Heart disease I00-I52 MET
I00-I99: Diseases of the circulatory system Heart arrhythmia I47-I49 F2
H60-H95: Diseases of the ear and mastoid process Hearing disorder H90.5 TP53
C00-D49: Neoplasms Head and neck cancer C07-C14, C32-C33 AKR1B1; TERT; EGFR; EGFR; EGFR; TP53; KDR; KDR
A00-B99: Certain infectious and parasitic diseases HCV infection B17.1, B18.2 MMP3
C00-D49: Neoplasms Head and neck squamous cell carcinoma C44 EGFR
C00-D49: Neoplasms AML NA FLT3; KDR
NA: NA Edema NA CA2
I00-I99: Diseases of the circulatory system Neurological disease I21, I22, R52, R52.1-R52.2, R60.9, G89 F2; ADRA2C; NPSR1; APP
C00-D49: Neoplasms Myelodysplastic syndrome D46 DNMT1; DNMT1; TEK; TLR2; KDR
C00-D49: Neoplasms Myelofibrosis C94.4, D47.4 FLT3
G00-G99: Diseases of the nervous system G00-G99 Myasthenia gravis G70.0 ACHE
G00-G99: Diseases of the nervous system G00-G99 Myasthenia gravis diagnosis G70.0 ACHE
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Schizophrenia F20 ESRRA; DRD4
L00-L99: Diseases of the skin and subcutaneous tissue Dermatological disease L00-L99 AR; ESRRA
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Depression F30-F39 MAOA; ADRA2C
L00-L99: Diseases of the skin and subcutaneous tissue Dermatitis L20-L30 ESRRA; PTGS1; ALOX5
NA: NA Haemophilia B NA F10
C00-D49: Neoplasms Haematological malignancies C81-C86 AURKA
H00-H59: Diseases of the eye and adnexa Graves' ophthalmopathy H06.2 IGF1R
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified Growth failure R62.8 IGF1R
H00-H59: Diseases of the eye and adnexa Age related macular degeneration H35.3 APP
C00-D49: Neoplasms Advanced solid tumor C00-C75, C7A, C7B MET; PIK3CG; PIK3CG; AURKA; PLK1
NA: NA Inflammatory diseases NA MAPK14
C00-D49: Neoplasms Inflammatory disease C11, C44, K75.9, M00-M25 MPO; PLA2G1B; MMP13; SYK; PIK3CG; PTGS1; ALOX5; MAPK14; FAAH
C00-D49: Neoplasms Inflammatory breast cancer C50 EGFR
K00-K95: Diseases of the digestive system Inflammatory bowel disease K50, K51 PTGS1; MAPK14; PPARG
L00-L99: Diseases of the skin and subcutaneous tissue Inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp L20-L30 PLA2G1B
E00-E89: Endocrine, nutritional and metabolic diseases Inflammation E08-E13, E10.2, E11, E11.2, E13.2, I73.9, I80-I82, N00-N29, G89 ALOX5
G00-G99: Diseases of the nervous system G00-G99 Parkinson's disease G20 MPO; MAOA; ACHE; BRAF
C00-D49: Neoplasms Pancreatic cancer C25 AKT1; TERT; FLT3; MMP2; EGFR; TLR2; KDR; PLK1
K00-K95: Diseases of the digestive system Peptic ulcer K25-K27 ADRA2C
A00-B99: Certain infectious and parasitic diseases Pediculus humanus capitis B85.0 ACHE
I00-I99: Diseases of the circulatory system Ischemia I99.8 SRC; TEK
C00-D49: Neoplasms Hormone refractory prostate cancer C61 AR
I00-I99: Diseases of the circulatory system High blood pressure I10-I16 CA2
NA: NA HIV infections NA AHR
C00-D49: Neoplasms Cancer C00-C96 AR; AKT1; MET; GSK3B; CSNK2A1; ABCB1; SYK; PIK3CG; CA1; FLT3; FLT3; CA9; F2; MMP2; ACHE; DNMT1; SRC; IGF1R; PTK2; BRAF; BRAF; AURKA; FLT4; EPHB4; TEK; HIF1A; CDK1; MAPK1; MAPK14; MMP9; ERBB2; ERBB2; EGFR; NFKB1; PIM1; TLR2; BCL2; BCL2; TP53; KDR; PLK1; APP
C00-D49: Neoplasms Cutaneous Melanoma C43-C44 KDR
C00-D49: Neoplasms Acute lymphoblastic leukemia C91.0 FLT3
C00-D49: Neoplasms Ovarian cancer C56 TERT; ABCB1; MMP2; EGFR; EGFR; KDR; KDR; KDR; KDR
M00-M99: Diseases of the musculoskeletal system and connective tissue Osteoporosis M80-M81, Z79.890 AR; SRC
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism Beta thalassemia D56.1 HBB
C00-D49: Neoplasms B-cell lymphoma C85.1 SYK
M00-M99: Diseases of the musculoskeletal system and connective tissue Osteoporosis in post-menopausal women M80-M81 AR
NA: NA Hematopoietic stem cell transplantation NA FLT3
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism Hemophilia D66-D68 F10
A00-B99: Certain infectious and parasitic diseases Helminth infection A00-B99 ACHE
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism Hematology D50-D77 F10
I00-I99: Diseases of the circulatory system Coronary artery disease I20-I25 MAPK14; MAPK14
C00-D49: Neoplasms Late-stage solid tumors C00-C75, C7A, C7B, D10-D36, D3A DNMT1; PTK2; BRAF; AURKA; TP53
C00-D49: Neoplasms Leukemia C90-C95 AKT1; FLT3; BCL2
A00-B99: Certain infectious and parasitic diseases Leishmaniasis B55.0 PLA2G1B
C00-D49: Neoplasms Late-stage non-small cell lung cancer C33-C34 EPHB4
C00-D49: Neoplasms Liver cancer C22 TERT; IGF1R; KDR
C00-D49: Neoplasms Prostate cancer C61 AR; AR; TERT; PIK3CG; FLT3; FLT4; ERBB2; EGFR; TLR2; BCL2; PLK1
N00-N99: Diseases of the genitourinary system Prostate hyperplasia N40 AR
C00-D49: Neoplasms Acute myeloid leukemia C92.0 TERT; FLT3; FLT3; DNMT1; DNMT1; AURKB; AURKA; TP53; TP53; PLK1
I00-I99: Diseases of the circulatory system Hypertension I10-I16 ADRA2C
C00-D49: Neoplasms Locally advanced head and neck cancer C07-C14, C32, C33 EGFR
C00-D49: Neoplasms Lung cancer C33-C34 MMP2; FLT4; EGFR
K00-K95: Diseases of the digestive system Liver disease K70-K77 MET; FAAH
C00-D49: Neoplasms Lymphoma C81-C86 AKT1; PIK3CG; PIK3CG; CA9; INSR; HIF1A; ERBB2; EGFR; BCL2; PLK1
C00-D49: Neoplasms Ocular cancer C69 APEX1
H00-H59: Diseases of the eye and adnexa Ocular inflammation H16.229 TERT; PPARG
H00-H59: Diseases of the eye and adnexa Open-angle glaucoma H40-H42 ACHE; CA4; CA2
H00-H59: Diseases of the eye and adnexa Ocular hypertension H40.0 ADRA2C; CA4; CA4
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism Thrombocytopenia D69.6, P61.0 F2
C00-D49: Neoplasms Hepatocellular carcinoma C22.0 MET; IGF1R; FLT4; KDR
E00-E89: Endocrine, nutritional and metabolic diseases Hunter syndrome E76.1 INSR
E00-E89: Endocrine, nutritional and metabolic diseases Hypercholesterolemia E78 INSR
N00-N99: Diseases of the genitourinary system Dysmenorrhea N94.4-N94.6 PTGS1
NA: NA Dyslipidemia NA PPARD
N00-N99: Diseases of the genitourinary system Prostate disease N42.9 CYP19A1
L00-L99: Diseases of the skin and subcutaneous tissue Pruritus L29 PLA2G1B; ALOX5
E00-E89: Endocrine, nutritional and metabolic diseases Hyperlipidaemia E78 INSR; PPARD
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Major depressive disorder F32, F33, M32 MAOA; MAOA; FAAH
NA: NA Male hypogonadism NA AR
E00-E89: Endocrine, nutritional and metabolic diseases Male hormonal deficiencies E20-E35 AR
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Male sexual disorders F52 ADRA2C
I00-I99: Diseases of the circulatory system Acute coronary syndrome I74 F10; MAPK14
I00-I99: Diseases of the circulatory system Stroke in atrial fibrillation I48, I61-I63 F2
H00-H59: Diseases of the eye and adnexa Chronic glaucoma H40-H42 CA1; ACHE
NA: NA Rheumatold arthritis NA PTGS1; MAPK14
C00-D49: Neoplasms Adrenocortical carcinoma C74.0 ABCB1
C00-D49: Neoplasms Medullary thyroid cancer C73 KDR
L00-L99: Diseases of the skin and subcutaneous tissue Melasma L81.1 TYR
C00-D49: Neoplasms Malignant tumor C00-C75, C7A, C7B EGFR
I00-I99: Diseases of the circulatory system Thrombosis I80-I82 F10; SYK; F2; F2; ALOX5
I00-I99: Diseases of the circulatory system Thromboembolic disorders I80-I82 F10
I00-I99: Diseases of the circulatory system Thromboembolism I80-I82 F10; F2
E00-E89: Endocrine, nutritional and metabolic diseases Testosterone deficiency E29.1 AR
C00-D49: Neoplasms Squamous cell cancer of head and neck NA KDR
C00-D49: Neoplasms Hematological malignancies C81-C86 SYK; SRC; AURKB; TP53
I00-I99: Diseases of the circulatory system Deep vein thrombosis I80-I82, I80.2 F10
E00-E89: Endocrine, nutritional and metabolic diseases Cystic fibrosis E84 AR
C00-D49: Neoplasms Metastatic castration-resistant prostate cancer C61 AR; KDR
C00-D49: Neoplasms Metastatic breast cancer C50 PIK3CG; KDR
S00-T88: Injury, poisoning and certain other consequences of external causes Postoperative inflammation T81 PTGS1
E00-E89: Endocrine, nutritional and metabolic diseases Pompe's disease E74.02 GAA
M00-M99: Diseases of the musculoskeletal system and connective tissue Rheumatoid arthritis M05-M06 CAMK2B; AKR1B1; PLA2G1B; ESRRA; SYK; MMP3; ALOX5; MAPK14; TYR
C00-D49: Neoplasms Fallopian tube cancer C57.0, D28.2 KDR
A00-B99: Certain infectious and parasitic diseases Lymphatic filariasis B74 ALOX5
L00-L99: Diseases of the skin and subcutaneous tissue Psoriatic disorder L40 IGF1R
I00-I99: Diseases of the circulatory system Heart failure I50 AR; XDH; ADRA2C
C00-D49: Neoplasms Metastatic melanoma C43 BRAF; BRAF
C00-D49: Neoplasms Metastatic colorectal cancer C18-C21 EGFR; KDR
C00-D49: Neoplasms Metastatic HER2-negative gastric cancer NA MET
C00-D49: Neoplasms Metastatic prostate cancer C61 AR
S00-T88: Injury, poisoning and certain other consequences of external causes Vulnerary S00-T98 EGFR
K00-K95: Diseases of the digestive system Xerostomia K11.7, R68.2 ACHE
M00-M99: Diseases of the musculoskeletal system and connective tissue Fibromyalgia M79.7 ADRA2C
L00-L99: Diseases of the skin and subcutaneous tissue Fibrosis L90.5 MET
C00-D49: Neoplasms Gastric cancer C16 ERBB2; EGFR; EGFR; KDR; KDR
C00-D49: Neoplasms Oral cavity cancer C00-C08 TP53
M00-M99: Diseases of the musculoskeletal system and connective tissue Osteoarthritis M15-M19, M47 MMP13; MMP3; MMP2; PTGS1; ALOX5
L00-L99: Diseases of the skin and subcutaneous tissue Contact dermatitis L23, L24, L25 PLA2G1B
NA: NA Miosis during ocular surgery NA PTGS1
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Mood disorder F30-F39 MAOA
F01-F99: Mental, Behavioral and Neurodevelopmental disorders Psychotic disorders F20-F29 DRD4
S00-T88: Injury, poisoning and certain other consequences of external causes Contusion S36.220S ADRA2C
Z00-Z99: Factors influencing health status and contact with health services Contraception Z30 AR
H00-H59: Diseases of the eye and adnexa Corneal ulcers H16.0 MMP3
C00-D49: Neoplasms Osteosarcoma C40-C41 GSK3B; SRC
E00-E89: Endocrine, nutritional and metabolic diseases Metabolic disorders E70-E89 PPARD
C00-D49: Neoplasms Metastasis C00-C97 AXL
G00-G99: Diseases of the nervous system G00-G99 Motor neurone disease G12.2 IGF1R
C00-D49: Neoplasms Multiple myeloma C90 AHR; TERT; SRC; IGF1R; BCL2
M00-M99: Diseases of the musculoskeletal system and connective tissue Muscle atrophy M62.5 AR
D50-D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism Blood forming organ disorders D75.9 F2
C00-D49: Neoplasms Colorectal cancer C18-C21 FLT3; PTGS1; IGF1R; MMP9; ERBB2; EGFR; EGFR; TP53; KDR
C00-D49: Neoplasms Colon cancer C50 FLT3; EGFR
E00-E89: Endocrine, nutritional and metabolic diseases Hormone deficiency E00-E90 AR; IGF1R
Data Section
Select to Download
1. General Info & Plant Usage & Geographical Distribution  
2. Human Target Proteins  
3. Target Gene Ontology  
4. Target KEGG Pathway  
5. Related Human Diseases  
About Us

The CMAUP database is developed by the Bioinformatics & Drug Design group (BIDD), which is based in the Department of Pharmacy, National University of Singapore, Singapore.

CMAUP

Home

About

Browse

Help

Useful links

BIDD home

NPASS database

TCM-ID database

TTD database

Contact

Singapore, 117549, National University of Singapore

Principle Investigator:
Prof. Chen Yu Zong
phacyz@nus.edu.sg

Developer & Maintainer:
Dr. Zeng Xian
zengxian@u.edu.nus

© 2018 Copyright: Bioinformatics & Drug Design group